다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Life sciences, v.267, 2021년, pp.118814 -
Ahmed, Semim Akhtar (Cell and Molecular Biology Laboratory, Department of Zoology, Cotton University) , Parama, Dey (Cancer Biology Laboratory and DBT-AIST International Center for Translational and Environmental Research (DAICENTER), Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati) , Daimari, Enush (Cell and Molecular Biology Laboratory, Department of Zoology, Cotton University) , Girisa, Sosmitha (Cancer Biology Laboratory and DBT-AIST International Center for Translational and Environmental Research (DAICENTER), Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati) , Banik, Kishore (Cancer Biology Laboratory and DBT-AIST International Center for Translational and Environmental Research (DAICENTER), Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati) , Harsha, Choudhary (Cancer Biology Laboratory and DBT-AIST International Center for Translational and Environment) , Dutta, Uma , Kunnumakkara, Ajaikumar B.
AI-Helper
Abstract Background Despite the remarkable advances made in the diagnosis and treatment of cancer during the past couple of decades, it remains the second largest cause of mortality in the world, killing approximately 9.6 million people annually. The major challenges in the treatment of the advance...
CA Cancer J. Clin. Bray 68 6 394 2018 10.3322/caac.21492 Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Cancer Lett. Banik 416 75 2018 10.1016/j.canlet.2017.12.014 Therapeutic potential of gambogic acid, a caged xanthone, to target cancer
Semin. Cancer Biol. Khatoon 2020 Phytochemicals in cancer cell chemosensitization: current knowledge and future perspectives
Recent Patents Anti-Cancer Drug Discov. Bordoloi 11 1 67 2016 10.2174/1574892810666151020101706 Multi-targeted agents in cancer cell chemosensitization: what we learnt from curcumin thus far
Pharmacol. Res. Sailo 130 259 2018 10.1016/j.phrs.2018.02.017 Tocotrienols: the promising analogues of vitamin E for cancer therapeutics
Int. J. Mol. Sci. Ranaware 19 8 2362 2018 10.3390/ijms19082362 Magnolol: a neolignan from the magnolia family for the prevention and treatment of cancer
Bordoloi 1 2018 Cancer Cell Chemoresistance and Chemosensitization Introduction and basic concepts of cancer
Pharm. Res. Anand 25 9 2097 2008 10.1007/s11095-008-9661-9 Cancer is a preventable disease that requires major lifestyle changes. Erratum in: Pharm Res. 2008 Sep;25(9):2200. Kunnumakara, Ajaikumar B [corrected to Kunnumakkara, Ajaikumar B]
Transl. Oncol. Shabnam 11 6 1379 2018 10.1016/j.tranon.2018.08.015 Sorcin a potential molecular target for cancer therapy
Eur. J. Med. Chem. Sharma 188 2020 10.1016/j.ejmech.2019.112016 Thiazole-containing compounds as therapeutic targets for cancer therapy
Lancet Glob. Health Plummer 4 9 e609 2016 10.1016/S2214-109X(16)30143-7 Global burden of cancers attributable to infections in 2012: a synthetic analysis
Br. J. Cancer Parkin 105 Suppl 2(Suppl 2) S77 2011 10.1038/bjc.2011.489 16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010
CA Cancer J. Clin. Jemal 61 2 69 2011 10.3322/caac.20107 Global cancer statistics. Erratum in CA Cancer J Clin. 2011 Mar-Apr;61(2):134
CA Cancer J. Clin. Torre 65 2 87 2015 10.3322/caac.21262 Global cancer statistics, 2012
J. Cell. Biochem. Aggarwal 102 3 580 2007 10.1002/jcb.21500 Targeting cell signaling pathways for drug discovery: an old lock needs a new key
Nutr. Cancer Shanmugam 63 2 161 2011 10.1080/01635581.2011.523502 Targeting cell signaling and apoptotic pathways by dietary agents: role in the prevention and treatment of cancer
Semin. Cancer Biol. Kirtonia 2020 Repurposing of drugs: An attractive pharmacological strategy for cancer therapeutics
Curr. Opin. Pharmacol. Khanna 7 3 344 2007 10.1016/j.coph.2007.03.002 Natural products as a gold mine for arthritis treatment
Cancer Lett. Liu 362 1 8 2015 10.1016/j.canlet.2015.03.019 Garcinol: current status of its anti-oxidative, anti-inflammatory and anti-cancer effects
J. Ethnopharmacol. Ajaikumar 96 1-2 171 2005 10.1016/j.jep.2004.09.007 The inhibition of gastric mucosal injury by Punicagranatum L. (pomegranate) methanolic extract
J. Immunol. (Baltimore, Md.: 1950) Nair 177 8 5612 2006 10.4049/jimmunol.177.8.5612 Deguelin, an Akt inhibitor, suppresses IkappaBalpha kinase activation leading to suppression of NF-kappaB-regulated gene expression, potentiation of apoptosis, and inhibition of cellular invasion
Phytomed. Int. J. Phytother. Phytopharmacol. Gupta 34 14 2017 Neem (Azadirachta indica): an indian traditional panacea with modern molecular basis
J. Med. Food Amalraj 20 10 1022 2017 10.1089/jmf.2017.3930 A novel highly bioavailable curcumin formulation improves symptoms and diagnostic indicators in rheumatoid arthritis patients: a randomized, double-blind, placebo-controlled, two-dose, three-arm, and parallel-group study
Phytother. Res. PTR Gopi 31 12 1883 2017 10.1002/ptr.5931 Comparative oral absorption of curcumin in a natural turmeric matrix with two other curcumin formulations: an open-label parallel-arm study
Experim. Biol. Med. (Maywood, N.J.) Dai 240 6 760 2015 10.1177/1535370215579167 Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy
Cancer Lett. Shanmugam 320 2 158 2012 10.1016/j.canlet.2012.02.037 Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: potential role in prevention and therapy of cancer
Cancer Lett. Roy 377 1 74 2016 10.1016/j.canlet.2016.04.017 The potential role of boswellic acids in cancer prevention and treatment
Curr. Pharm. Des. Monisha 22 27 4173 2016 10.2174/1381612822666160609110231 NF-κB blockers gifted by mother nature: prospectives in cancer cell chemosensitization
Cancers Sailo 11 2 246 2019 10.3390/cancers11020246 FBXW7 in cancer: what has been unraveled thus far?
Int. J. Mol. Sci. Bordoloi 19 10 2974 2018 10.3390/ijms19102974 TIPE family of proteins and its implications in different chronic diseases
Br. J. Pharmacol. Kunnumakkara 174 11 1325 2017 10.1111/bph.13621 Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases
Clin. Sci. (Lond. Engl. 1979) Kunnumakkara 131 15 1781 2017 10.1042/CS20160935 Curcumin mediates anticancer effects by modulating multiple cell signaling pathways
Monisha 15 2017 Cancer Cell Chemoresistance and Chemosensitization Cancer cell chemoresistance: a prime obstacle in cancer therapy
J. Mol. Med. (Berlin, Germany) Khwairakpam 98 1 71 2020 10.1007/s00109-019-01863-0 The vital role of ATP citrate lyase in chronic diseases
Semin. Cancer Biol. Kashyap 2019 Natural product-based nanoformulations for cancer therapy: opportunities and challenges
Molecules (Basel, Switzerland) Merarchi 24 6 1047 2019 10.3390/molecules24061047 Role of natural products in modulating histone deacetylases in cancer
Curr. Vasc. Pharmacol. Shanmugam 15 6 503 2017 10.2174/1570161115666170713094319 Potential role of natural compounds as anti-angiogenic agents in cancer
Cancer Lett. Kunnumakkara 269 2 199 2008 10.1016/j.canlet.2008.03.009 Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins
Semin. Cancer Biol. Patel 40-41 100 2016 10.1016/j.semcancer.2016.03.002 Potential of neem (Azadirachta indica L.) for prevention and treatment of oncologic diseases
Biomed. Res. Int. Rahmani 2014 761608 2014 10.1155/2014/761608 Curcumin: a potential candidate in prevention of cancer via modulation of molecular pathways
J. Colloid Interface Sci. Banerjee 491 98 2017 10.1016/j.jcis.2016.12.025 Enhanced chemotherapeutic efficacy of apigenin liposomes in colorectal cancer based on flavone-membrane interactions
Metabolites Dias 2 2 303 2012 10.3390/metabo2020303 A historical overview of natural products in drug discovery
Semin. Cancer Biol. Shanmugam 40-41 35 2016 10.1016/j.semcancer.2016.03.005 Cancer prevention and therapy through the modulation of transcription factors by bioactive natural compounds
Phytomed. Int. J. Phytother. Phytopharmacol. Padmavathi 25 118 2017 Butein in health and disease: a comprehensive review
Life Sci. Parama 118182 2020 Diosgenin, a steroidal saponin, and its analogues: effective therapies against different chronic diseases
Biomed. Res. Int. Hsieh 2015 182835 2015 10.1155/2015/182835 Natural bioactives in cancer treatment and prevention
Evidence-based Complement. Altern. Med. eCAM. Yang 2013 698190 2013 10.1155/2013/698190 Natural bioactives and phytochemicals serve in cancer treatment and prevention
J. Nat. Prod. Newman 79 3 629 2016 10.1021/acs.jnatprod.5b01055 Natural products as sources of new drugs from 1981 to 2014
Heneman 1 2008 Nutrition and Health Info Sheet: Phytochemicals, ANR Publication 8313
Cancer Res. Kunnumakkara 70 21 8695 2010 10.1158/0008-5472.CAN-10-2318 {Gamma}-tocotrienol inhibits pancreatic tumors and sensitizes them to gemcitabine treatment by modulating the inflammatory microenvironment
Cancer Prev. Res. (Phila.) Millimouno 7 11 1081 2014 10.1158/1940-6207.CAPR-14-0136 Targeting apoptosis pathways in cancer and perspectives with natural compounds from mother nature
Biochem. Pharmacol. Prasannan 84 10 1268 2012 10.1016/j.bcp.2012.07.015 Key cell signaling pathways modulated by zerumbone: role in the prevention and treatment of cancer
Aggarwal 2009 Molecular Targets and Therapeutic Uses of Spices: Modern Uses for Ancient Medicine
Pharmacol. Res. Khwairakpam 133 53 2018 10.1016/j.phrs.2018.04.021 Possible use of Punica granatum (pomegranate) in cancer therapy
Kunnumakkara 1 2009 Molecular Targets and Therapeutic Uses of Spices Traditional uses of spices: an overview
Expert Opin. Drug Metab. Toxicol. Kunnumakkara 15 9 705 2019 10.1080/17425255.2019.1650914 Is curcumin bioavailability a problem in humans: lessons from clinical trials
Food Chem. Toxicol. Int. J. Brit. Ind. Biol. Res. Assoc. Harsha 108 Pt A 104 2017 10.1016/j.fct.2017.07.023 Antiulcer properties of fruits and vegetables: a mechanism based perspective
Biomedicines Merarchi 7 3 53 2019 10.3390/biomedicines7030053 A brief overview of the antitumoral actions of leelamine
Int. J. Mol. Sci. Roy 20 17 4101 2019 10.3390/ijms20174101 An update on pharmacological potential of Boswellic acids against chronic diseases
Kunnumakkara 2013 Anticancer Properties of Fruits and Vegetables
J. Basic Clin. Physiol. Pharmacol. Khwairakpam 29 2 107 2018 10.1515/jbcpp-2016-0132 Acorus calamus: a bio-reserve of medicinal values
J. Basic Clin. Physiol. Pharmacol. Khwairakpam 31 3 2019 Vietnamese coriander inhibits cell proliferation, survival and migration via suppression of Akt/mTOR pathway in oral squamous cell carcinoma
Mol. Carcinog. Shanmugam 54 10 971 2015 10.1002/mc.22166 Abrogation of STAT3 signaling cascade by zerumbone inhibits proliferation and induces apoptosis in renal cell carcinoma xenograft mouse model
Molecules (Basel, Switzerland) Henamayee 25 10 2278 2020 10.3390/molecules25102278 Therapeutic emergence of rhein as a potential anticancer drug: a review of its molecular targets and anticancer properties
Planta Med. Aggarwal 74 13 1560 2008 10.1055/s-2008-1074578 Potential of spice-derived phytochemicals for cancer prevention
Biochem. Pharmacol. Goel 75 4 787 2008 10.1016/j.bcp.2007.08.016 Curcumin as “curecumin”: from kitchen to clinic
Kunnumakkara 373 2009 Molecular Targets and Therapeutic Uses of Spices Mint and its constituents
Kunnumakkara 455 2009 DNA Damage and Cancer Chemoprevention by Polyphenols, Chemoprevention of Cancer and DNA Damage by Dietary Factors
Pharmacol. Res. Shanmugam 129 357 2018 10.1016/j.phrs.2017.11.023 Modulation of diverse oncogenic transcription factors by thymoquinone, an essential oil compound isolated from the seeds of Nigella sativa Linn
Cancers Ong 11 5 611 2019 10.3390/cancers11050611 Focus on Formononetin: anticancer potential and molecular targets
Phytomed. Int. J. Phytother. Phytopharmacol. Padmavathi 22 13 1163 2015 Potential of butein, a tetrahydroxychalcone to obliterate cancer
J. Experim. Clin. Cancer Res. CR Babu 22 4 581 2003 Free radical scavenging, antitumor and anticarcinogenic activity of gossypin
Front. Pharmacol. Nurgali 9 245 2018 10.3389/fphar.2018.00245 Editorial: adverse effects of cancer chemotherapy: anything new to improve tolerance and reduce sequelae?
Int. J. Mol. Sci. Salehi 20 6 1305 2019 10.3390/ijms20061305 The therapeutic potential of apigenin
Blood Kunnumakkara 109 12 5112 2007 10.1182/blood-2007-01-067256 Gossypin, a pentahydroxy glucosyl flavone, inhibits the transforming growth factor beta-activated kinase-1-mediated NF-kappaB activation pathway, leading to potentiation of apoptosis, suppression of invasion, and abrogation of osteoclastogenesis
Pharmacol. Res. Banik 144 192 2019 10.1016/j.phrs.2019.04.004 Honokiol for cancer therapeutics: a traditional medicine that can modulate multiple oncogenic targets
Experim. Biol. Med. (Maywood, N.J.) Kunnumakkara 244 8 663 2019 10.1177/1535370219839163 Cancer drug development: the missing links
Molecules (Basel, Switzerland) Girisa 24 4 734 2019 10.3390/molecules24040734 Potential of zerumbone as an anti-cancer agent
Crit. Rev. Food Sci. Nutr. Bishayee 56 10 1753 2016 10.1080/10408398.2014.982243 Potential benefits of edible berries in the management of aerodigestive and gastrointestinal tract cancers: preclinical and clinical evidence
Oncotarget Siveen 5 3 634 2014 10.18632/oncotarget.1596 Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-κB regulated gene products in multiple myeloma xenograft mouse model
Semin. Cancer Biol. Mohan 2020 Targeting STAT3 signaling pathway in cancer by agents derived from mother nature
Cell Biosci. Yan 7 50 2017 10.1186/s13578-017-0179-x Apigenin in cancer therapy: anti-cancer effects and mechanisms of action
J. Aerosol Med. Pulmon. Drug Deliv. Pápay 30 4 274 2017 10.1089/jamp.2016.1316 Study on the pulmonary delivery system of apigenin-loaded albumin nanocarriers with antioxidant activity
Food Chem. Toxicol. Int. J. Brit. Ind. Biol. Res. Assoc. Wang 53 376 2013 10.1016/j.fct.2012.12.018 In vitro anti-inflammatory effect of apigenin in the Helicobacter pylori-infected gastric adenocarcinoma cells
Int. J. Pharm. Sci. Rev. Res. Lakshmi 9 136 2011 Yarrow (Achillea millefolium Linn.) a herbal medicinal plant with broad therapeutic use - a review
Evidence-based Complem. Altern. Med. eCAM Street 2013 579319 2013 Cichorium intybus: traditional uses, phytochemistry, pharmacology, and toxicology
J. Ethnopharmacol. Csupor 127 1 193 2010 10.1016/j.jep.2009.09.049 The traditional Hungarian medicinal plant Centaurea sadleriana Janka accelerates wound healing in rats
Franke 2005 Chamomile: Industrial Profiles
Gardner 2013 American Herbal Products Association's Botanical Safety Handbook
Am. J. Chin. Med. Lin 22 2 155 1994 10.1142/S0192415X9400019X Hepatoprotective effects of Taiwan folk medicine: wedelia chinensis on three hepatotoxin-induced hepatotoxicity
Adv. Nutr. (Bethesda, Md.) Hostetler 8 3 423 2017 10.3945/an.116.012948 Flavones: food sources, bioavailability, metabolism, and bioactivity
J. Anal. Methods Chem. Głowacki 2016 2016 10.1155/2016/3827832 Determination of total apigenin in herbs by micellar electrokinetic chromatography with UV detection
J. Agric. Food Chem. Chun 51 25 7240 2003 10.1021/jf0343579 Contribution of individual polyphenolics to total antioxidant capacity of plums
J. Agric. Food Chem. Innocenti 55 16 6596 2007 10.1021/jf070257h Flavonoids and biflavonoids in Tuscan berries of Juniperus communis L.: detection and quantitation by HPLC/DAD/ESI/MS
Acta Alimentaria ACTA ALIMENT Lugast 29 345 2000 10.1556/AAlim.29.2000.4.4 Flavonoid aglycons in foods of plant origin I. Vegetables
Food Chem. Trichopoulou 70 3 319 2000 10.1016/S0308-8146(00)00091-1 Nutritional composition and flavonoid content of edible wild greens and green pies: a potential rich source of antioxidant nutrients in the Mediterranean diet
Int. J. Food Sci. Nutr. Chun 55 3 191 2004 10.1080/09637480410001725148 Antioxidant properties of raw and processed cabbages
Food Chem. Škerget 89 2 191 2005 10.1016/j.foodchem.2004.02.025 Phenols, proanthocyanidins, flavones and flavonols in some plant materials and their antioxidant activities
J. Sci. Food Agric. Bahorun 84 12 1553 2004 10.1002/jsfa.1820 Total phenol, flavonoid, proanthocyanidin and vitamin C levels and antioxidant activities of Mauritian vegetables
Food Chem. Dykes 116 1 313 2009 10.1016/j.foodchem.2009.02.052 Flavonoid composition of red sorghum genotypes
J. Agric. Food Chem. Dietrych-Szostak 47 10 4384 1999 10.1021/jf990121m Effect of processing on the flavonoid content in buckwheat (Fagopyrum esculentum Möench) grain
Fitoterapia Carnat 75 1 32 2004 10.1016/j.fitote.2003.07.007 The aromatic and polyphenolic composition of Roman camomile tea
Bhagwat 1 2011 USDA Database for the Flavonoid Content of Selected Foods
Food Chem. Wojdyło 105 3 940 2007 10.1016/j.foodchem.2007.04.038 Antioxidant activity and phenolic compounds in 32 selected herbs
J. Sci. Food Agric. Chu 80 561 2000 10.1002/(SICI)1097-0010(200004)80:5<561::AID-JSFA574>3.0.CO;2-# Flavonoid content of several vegetables and their antioxidant activity
J. Food Compos. Anal. Franke 17 1 1 2004 10.1016/S0889-1575(03)00066-8 Vitamin C and flavonoid levels of fruits and vegetables consumed in Hawaii
J. Agric. Food Chem. Sakakibara 51 3 571 2003 10.1021/jf020926l Simultaneous determination of all polyphenols in vegetables, fruits, and teas
Nutrition (Burbank, Los Angeles County, Calif.) Sartelet 12 2 100 1996 10.1016/0899-9007(96)90707-8 Flavonoids extracted from fonio millet (Digitaria exilis) reveal potent antithyroid properties
Pharmacogn. Rev. Al-Asmari 11 21 13 2017 10.4103/phrev.phrev_35_16 An updated phytopharmacological review on medicinal plant of Arab region: Apium graveolens Linn
J. Tradit. Chin. Med. Chung i Tsa Chih Ying Wen Pan Farzaei 33 6 815 2013 Parsley: a review of ethnopharmacology, phytochemistry and biological activities
J. Med. Food Shebaby 18 7 745 2015 10.1089/jmf.2014.3225 Daucus carota pentane-based fractions suppress proliferation and induce apoptosis in human colon adenocarcinoma HT-29 cells by inhibiting the MAPK and PI3K pathways
IOSR J. Pharm. Al-Snafi 6 3 41 2016 Medical importance of Cichorium intybus-a review
Molecules (Basel, Switzerland) Cruz 17 2 1535 2012 10.3390/molecules17021535 Carotenoids of lettuce (Lactuca sativa L.) grown on soil enriched with spent coffee grounds
Int. J. Adv. Biol. Biomed. Res. Zadeh 2 3 823 2014 Chamomile (Matricaria recutita) as a valuable medicinal plant
S. Afr. J. Bot. Devrnja 111 212 2017 10.1016/j.sajb.2017.03.028 Comparative studies on the antimicrobial and cytotoxic activities of Tanacetum vulgare L. essential oil and methanol extracts
Int. J. Pharm. Sci. Drug Res. Adhikari 4 110 2012 A review on medicinal importance of Basella alba L
Molecules (Basel, Switzerland) Bhandari 20 1 1228 2015 10.3390/molecules20011228 Chemical composition and antioxidant activity in different tissues of brassica vegetables
J. Food Eng. Gonçalves 93 32 2009 10.1016/j.jfoodeng.2008.12.027 Biochemical and colour changes of watercress (Nasturtium officinale R. Br.) during freezing and frozen storage
Indian J. Med. Sci. Manvar 67 3-4 49 2013 10.4103/0019-5359.121115 Phytochemical and pharmacological profile of Ipomoea aquatica
Rev. Bras Meira 22 682 2012 Review of the genus Ipomoea: traditional uses, chemistry and biological activities
Am. J. Phytomed. Clin. Ther. Shaheen 4 127 2016 Health promoting potential benefits of Vaccinium macrocarpon
Mol. Nutr. Food Res. Nagulapalli Venkata 61 6 2017 10.1002/mnfr.201600950 A small plant with big benefits: fenugreek (Trigonella foenum-graecum Linn.) for disease prevention and health promotion
Pharm. Res. Rao 3 2 143 2011 Chemical constituents and biological studies of Origanum vulgare Linn
Songklanakarin J. Sci. Technol. Mahboubi 36 83 2014 Chemical composition and antimicrobial activity of peppermint (Mentha piperita L.) essential oil
J. Food Drug Anal. Lou 25 1 162 2017 10.1016/j.jfda.2016.10.024 Phenolic compounds and biological activities of small-size citrus: kumquat and calamondin
J. Pharm. Biol. Al-Snafi 5 3 124 2015 The pharmacological importance of capsicum species (Capsicum annuum and Capsicum frutescens) grown in Iraq
Mol. Med. Rep. Srivastava 3 6 895 2010 Chamomile: a herbal medicine of the past with bright future
Evidence-based Complement. Altern. Med. eCAM Salem 2017 4951937 2017 Chemicals compositions, antioxidant and anti-inflammatory activity of Cynara scolymus leaves extracts, and analysis of major bioactive polyphenols by HPLC
Nutr. Cancer Jain 34 2 173 1999 10.1207/S15327914NC3402_8 Plant foods, antioxidants, and prostate cancer risk: findings from case-control studies in Canada
Appl. Environ. Microbiol. Leonard 71 12 8241 2005 10.1128/AEM.71.12.8241-8248.2005 Investigation of two distinct flavone synthases for plant-specific flavone biosynthesis in Saccharomyces cerevisiae
Pharm. Res. Shukla 27 6 962 2010 10.1007/s11095-010-0089-7 Apigenin: a promising molecule for cancer prevention
Int. J. Pharm. Zhang 436 1-2 311 2012 10.1016/j.ijpharm.2012.07.002 Biopharmaceutics classification and intestinal absorption study of apigenin
Int. J. Oncol. Patel 30 1 233 2007 Apigenin and cancer chemoprevention: progress, potential and promise (review)
Int. J. Food Prop. Ali 20 6 1197 2017 10.1080/10942912.2016.1207188 Health functionality of apigenin: a review
Recent Patents Inflamm. Allergy Drug Discov. Sharma 13 2 124 2019 10.2174/1872213X13666190816160240 Probing into therapeutic anti-cancer potential of apigenin: recent trends and future directions
Front. Microbiol. Marín 8 921 2017 10.3389/fmicb.2017.00921 De novo biosynthesis of Apigenin, Luteolin, and Eriodictyol in the Actinomycete Streptomyces albus and production improvement by feeding and spore conditioning
J. Chem. Soc. (Resumed) Hutchins 91 1939 10.1039/jr9390000091 17. Chalkones: a new synthesis of chrysin, apigenin, and luteolin
NCBI, National Center for Biotechnology Information
Phytochemistry Hooper 71 8-9 904 2010 10.1016/j.phytochem.2010.02.015 Isoschaftoside, a C-glycosylflavonoid from Desmodium uncinatum root exudate, is an allelochemical against the development of Striga
Phytochemistry Hamilton 84 169 2012 10.1016/j.phytochem.2012.08.005 Elucidation of the biosynthesis of the di-C-glycosylflavone isoschaftoside, an allelopathic component from Desmodium spp. that inhibits Striga spp. development
NCBI, National Center for Biotechnology Information
J. Chem. Ecol. Kim 11 4 441 1985 10.1007/BF00989555 Isolation ofC-glycosylflavones as probing stimulant of planthoppers in rice plant
NCBI, National Center for Biotechnology Information
J. Med. Food Lim 19 11 1032 2016 10.1089/jmf.2016.0074 Apigetrin from Scutellaria baicalensis Georgi inhibits neuroinflammation in BV-2 microglia and exerts neuroprotective effect in HT22 hippocampal cells
Biochem. Biophys. Res. Commun. Sun 498 1 164 2018 10.1016/j.bbrc.2018.02.009 Apigetrin inhibits gastric cancer progression through inducing apoptosis and regulating ROS-modulated STAT3/JAK2 pathway
NCBI, National Center for Biotechnology Information
Food Funct. Hu 7 2 1002 2016 10.1039/C5FO01212K Apigenin-7-O-β-D-glucuronide inhibits LPS-induced inflammation through the inactivation of AP-1 and MAPK signaling pathways in RAW 264.7 macrophages and protects mice against endotoxin shock
Drug Invent. Today Kamalakararao 10 3552 2018 Effect of isolated bioactive flavonoid apigenin-7-o-β-d-glucuronide methyl ester on cyclooxygenase-2 gene expression in the breast cancer MCF-7 cell lines
NCBI, National Center for Biotechnology Information
Molecules (Basel, Switzerland) Meng 14 1 133 2008 10.3390/molecules14010133 Antioxidant activities of polyphenols extracted from Perilla frutescens varieties
Molecules (Basel, Switzerland) Kim 23 7 1777 2018 10.3390/molecules23071777 Aqueous extract of Perilla frutescens var. acuta relaxes the ciliary smooth muscle by increasing NO/cGMP content in vitro and in vivo
Phytochemistry Gurni 21 9 2428 1982 10.1016/0031-9422(82)85229-1 Apigeninidin as a leucoderivative in Ephedra frustillata
J. Chem. Soc. Perkin Trans. Costantino 2 2 227 1995 10.1039/p29950000227 Quantitative measurement of proton dissociation and tautomeric constants of apigeninidin
J. Sci. Food Agric. Akogou 99 4 2014 2019 10.1002/jsfa.9427 Application of apigeninidin-rich red sorghum biocolorant in a fermented food improves product quality
J. Food Sci. Geera 77 5 C566 2012 10.1111/j.1750-3841.2012.02668.x New highly stable dimeric 3-deoxyanthocyanidin pigments from Sorghum bicolor leaf sheath
NCBI, National Center for Biotechnology Information
J. Agric. Food Chem. Ghanta 55 26 10962 2007 10.1021/jf071892q Oxidative DNA damage preventive activity and antioxidant potential of Stevia rebaudiana (Bertoni) Bertoni, a natural sweetener
NCBI, National Center for Biotechnology Information
Iranian journal of pharmaceutical research Gohari 10 2 247 2011 Flavones and flavone glycosides from Salvia macrosiphon Boiss
Phytochemistry Nordby 7 9 1653 1968 10.1016/S0031-9422(00)88619-7 Apigenin 7β-rutinoside, a new flavonoid from the leaves of Citrus paradisi
Molecules (Basel, Switzerland) Nagy 14 1 509 2009 10.3390/molecules14010509 Antimutagenic activity and radical scavenging activity of water infusions and phenolics from ligustrum plants leaves
Eur. J. Med. Chem. Pan 122 674 2016 10.1016/j.ejmech.2016.07.015 Total synthesis of 8-(6″-umbelliferyl)-apigenin and its analogs as anti-diabetic reagents
Trends Food Sci. Technol. Boskou 17 505 2006 10.1016/j.tifs.2006.04.004 Sources of natural phenolic antioxidants
Food Chem Toxicol Kowalska 136 111016 2020 10.1016/j.fct.2019.111016 A comparison of the effects of apigenin and seven of its derivatives on selected biomarkers of oxidative stress and coagulation in vitro
Nutr. Cancer Miccadei 60 2 276 2008 10.1080/01635580801891583 Antioxidative and apoptotic properties of polyphenolic extracts from edible part of artichoke (Cynara scolymus L.) on cultured rat hepatocytes and on human hepatoma cells
Biochem. Pharmacol. Comalada 72 8 1010 2006 10.1016/j.bcp.2006.07.016 Inhibition of pro-inflammatory markers in primary bone marrow-derived mouse macrophages by naturally occurring flavonoids: analysis of the structure-activity relationship
Int. Immunopharmacol. Funakoshi-Tago 11 9 1150 2011 10.1016/j.intimp.2011.03.012 Anti-inflammatory activity of structurally related flavonoids, apigenin, luteolin and fisetin
Inflammation Wang 37 6 2085 2014 10.1007/s10753-014-9942-x Anti-inflammatory effects of apigenin in lipopolysaccharide-induced inflammatory in acute lung injury by suppressing COX-2 and NF-kB pathway
Mutat. Res. Kuo 270 2 87 1992 10.1016/0027-5107(92)90119-M Genotoxicities of nitropyrenes and their modulation by apigenin, tannic acid, ellagic acid and indole-3-carbinol in the Salmonella and CHO systems
J. Nutr. Van Dross 133 11 Suppl 1 3800s 2003 10.1093/jn/133.11.3800S The chemopreventive bioflavonoid apigenin modulates signal transduction pathways in keratinocyte and colon carcinoma cell lines
Anticancer Res. Birt 17 1a 85 1997 Inhibition of ultraviolet light induced skin carcinogenesis in SKH-1 mice by apigenin, a plant flavonoid
Toxicol. Appl. Pharmacol. Lee 226 2 178 2008 10.1016/j.taap.2007.09.013 Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells
Cell Death Dis. Ruela-de-Sousa 1 1 e19 2010 10.1038/cddis.2009.18 Cytotoxicity of apigenin on leukemia cell lines: implications for prevention and therapy
Free Radic. Biol. Med. Shukla 44 10 1833 2008 10.1016/j.freeradbiomed.2008.02.007 Apigenin-induced prostate cancer cell death is initiated by reactive oxygen species and p53 activation
Evidence-based Complement. Altern. Med. eCAM Ju 2015 186436 2015 10.1155/2015/186436 The flavonoid apigenin ameliorates cisplatin-induced nephrotoxicity through reduction of p53 activation and promotion of PI3K/Akt pathway in human renal proximal tubular epithelial cells
J. Chem. Pharm. Res. Hussein 7 996 2015 New approach in treatment of brain injury: neurotrophic effects of apigenin
Bioorg. Med. Chem. Wang 22 5 1515 2014 10.1016/j.bmc.2014.01.038 Synthesis, nitric oxide release, and α-glucosidase inhibition of nitric oxide donating apigenin and chrysin derivatives
Evidence-based Complement. Altern. Med. eCAM Pamunuwa 2016 8243215 2016 10.1155/2016/8243215 Antidiabetic properties, bioactive constituents, and other therapeutic effects of Scoparia dulcis
Am. J. Clin. Nutr. Janssen 67 2 255 1998 10.1093/ajcn/67.2.255 Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: results from an in vitro and a dietary supplement study
J. Agric. Food Chem. Yano 54 14 5203 2006 10.1021/jf0607361 Dietary apigenin suppresses IgE and inflammatory cytokines production in C57BL/6N mice
Immunopharmacol. Immunotoxicol. Li 32 3 364 2010 10.3109/08923970903420566 Apigenin inhibits allergen-induced airway inflammation and switches immune response in a murine model of asthma
FEMS Microbiol. Lett. Dong 338 2 124 2013 10.1111/1574-6968.12040 Apigenin alleviates the symptoms of Staphylococcus aureus pneumonia by inhibiting the production of alpha-hemolysin
Appl. Environ. Microbiol. Xia 82 1 87 2016 10.1128/AEM.02581-15 Combination therapy of LysGH15 and apigenin as a new strategy for treating pneumonia caused by Staphylococcus aureus
Virology Shibata 462-463 42 2014 10.1016/j.virol.2014.05.024 The flavonoid apigenin inhibits hepatitis C virus replication by decreasing mature microRNA122 levels
J. Nat. Prod. Fonseca-Silva 78 4 880 2015 10.1021/acs.jnatprod.5b00011 Effect of apigenin on leishmania amazonensis is associated with reactive oxygen species production followed by mitochondrial dysfunction
Pharm. Biol. Ozçelik 49 4 396 2011 10.3109/13880209.2010.519390 Cytotoxicity, antiviral and antimicrobial activities of alkaloids, flavonoids, and phenolic acids
Mycoses Singh 57 8 497 2014 10.1111/myc.12188 Treatment of dermatophytosis by a new antifungal agent ‘apigenin’
J. Anal. Biosci. Chakravarthi 32 320 2009 Apoptosis and expression of bcl-2 in cyclosporin induced renal damage and its reversal by beneficial effects of 4,5,7 - trihydroxyflavone
Chem. Biol. Interact. Shin 182 1 29 2009 10.1016/j.cbi.2009.07.016 Apigenin-induced apoptosis is mediated by reactive oxygen species and activation of ERK1/2 in rheumatoid fibroblast-like synoviocytes
Arthritis Res. Ther. Kang 11 2 R59 2009 10.1186/ar2682 Apigenin, a non-mutagenic dietary flavonoid, suppresses lupus by inhibiting autoantigen presentation for expansion of autoreactive Th1 and Th17 cells
Biochem. Pharmacol. Verbeek 68 4 621 2004 10.1016/j.bcp.2004.05.012 The flavones luteolin and apigenin inhibit in vitro antigen-specific proliferation and interferon-gamma production by murine and human autoimmune T cells
Food Chem. Toxicol. Int. J. Brit. Ind. Biol. Res. Assoc. Choi 64 27 2014 10.1016/j.fct.2013.11.020 Effects of C-glycosylation on anti-diabetic, anti-Alzheimer's disease and anti-inflammatory potential of apigenin
Molecules (Basel, Switzerland) Zhao 18 8 9949 2013 10.3390/molecules18089949 Neuroprotective, anti-amyloidogenic and neurotrophic effects of apigenin in an Alzheimer's disease mouse model
Neuropharmacology Patil 86 192 2014 10.1016/j.neuropharm.2014.07.012 Neuroprotective and neurotrophic effects of Apigenin and Luteolin in MPTP induced parkinsonism in mice
Zhong Yao Cai Zhongyaocai J. Chin. Med. Mater. Liu 31 6 870 2008 Neuroprotective effects of apigenin on acute transient focal cerebral ischemia-reperfusion injury in rats
Biomed. Res. Int. Tsalkidou 2014 157216 2014 10.1155/2014/157216 The effects of apigenin on the expression of Fas/FasL apoptotic pathway in warm liver ischemia-reperfusion injury in rats
Experim. Ther. Med. Zhang 13 5 1719 2017 10.3892/etm.2017.4165 Apigenin in the regulation of cholesterol metabolism and protection of blood vessels
Biomed. Aging Pathol. Alibabaei 4 4 355 2014 10.1016/j.biomag.2014.07.003 Matricaria chamomilla extract demonstrates antioxidant properties against elevated rat brain oxidative status induced by amnestic dose of scopolamine
J. Alzheimer's Dis. JAD Liu 24 1 85 2011 10.3233/JAD-2010-101593 The flavonoid apigenin protects brain neurovascular coupling against amyloid-β₂₅₋₃₅-induced toxicity in mice
Phytomed. Int. J. Phytother. Phytopharmacol. Mao 23 14 1735 2016 Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: a randomized clinical trial
Sleep Med. Rev. Leach 24 1 2015 10.1016/j.smrv.2014.12.003 Herbal medicine for insomnia: a systematic review and meta-analysis
Cancer Cell Int. Shi 15 33 2015 10.1186/s12935-015-0186-0 Apigenin, a dietary flavonoid, inhibits proliferation of human bladder cancer T-24 cells via blocking cell cycle progression and inducing apoptosis
Chin. J. Cancer Res. Chung-kuo Yen Cheng Yen Chiu Cao 25 2 212 2013 Autophagy inhibition enhances apigenin-induced apoptosis in human breast cancer cells
Oncol. Rep. Zhao 37 4 2277 2017 10.3892/or.2017.5450 Apigenin inhibits proliferation and invasion, and induces apoptosis and cell cycle arrest in human melanoma cells
Anti Cancer Agents Med. Chem. Tong 13 7 971 2013 10.2174/18715206113139990119 Targeting the PI3K/Akt/mTOR axis by apigenin for cancer prevention
Oncotarget Shukla 6 31 31216 2015 10.18632/oncotarget.5157 Apigenin blocks IKKα activation and suppresses prostate cancer progression
Sci. Rep. Cao 6 21731 2016 10.1038/srep21731 Inhibition of the STAT3 signaling pathway contributes to apigenin-mediated anti-metastatic effect in melanoma
Oncol. Rep. Liu 34 2 1035 2015 10.3892/or.2015.4022 Apigenin inhibits the proliferation and invasion of osteosarcoma cells by suppressing the Wnt/β-catenin signaling pathway
Cell Johnstone 108 2 153 2002 10.1016/S0092-8674(02)00625-6 Apoptosis: a link between cancer genetics and chemotherapy
Toxicol. Pathol. Elmore 35 4 495 2007 10.1080/01926230701320337 Apoptosis: a review of programmed cell death
Biomolecules Aggarwal 9 11 735 2019 10.3390/biom9110735 Role of reactive oxygen species in cancer progression: molecular mechanisms and recent advancements
Green 2011 Means to an End: Apoptosis and Other Cell Death Mechanisms
Cell Hanahan 100 1 57 2000 10.1016/S0092-8674(00)81683-9 The hallmarks of cancer
Nat. Rev. Mol. Cell Biol. Taylor 9 3 231 2008 10.1038/nrm2312 Apoptosis: controlled demolition at the cellular level
Cell. Mol. Life Sci. CMLS Kirtonia 2020 10.1007/s00018-020-03536-5 The multifaceted role of reactive oxygen species in tumorigenesis
Oncotarget Dai 8 8 12831 2017 10.18632/oncotarget.14606 A novel benzimidazole derivative, MBIC inhibits tumor growth and promotes apoptosis via activation of ROS-dependent JNK signaling pathway in hepatocellular carcinoma
Mol. Cancer Ther. Budhraja 11 1 132 2012 10.1158/1535-7163.MCT-11-0343 Apigenin induces apoptosis in human leukemia cells and exhibits anti-leukemic activity in vivo
Mol. Cancer Zhao 10 104 2011 10.1186/1476-4598-10-104 Apigenin inhibits proliferation and induces apoptosis in human multiple myeloma cells through targeting the trinity of CK2, Cdc37 and Hsp90
J. Agric. Food Chem. Lin 60 45 11395 2012 10.1021/jf303446x Apigenin induces apoptosis through mitochondrial dysfunction in U-2 OS human osteosarcoma cells and inhibits osteosarcoma xenograft tumor growth in vivo
Chem. Biol. Interact. Wang 206 2 346 2013 10.1016/j.cbi.2013.10.009 Synergistic anti-glioma effect of Hydroxygenkwanin and Apigenin in vitro
Biosci. Rep. Seo 35 6 2015 10.1042/BSR20150165 Induction of caspase-dependent extrinsic apoptosis by apigenin through inhibition of signal transducer and activator of transcription 3 (STAT3) signalling in HER2-overexpressing BT-474 breast cancer cells
Mol. Med. Rep. Seo 12 2 2977 2015 10.3892/mmr.2015.3698 Apigenin induces caspase-dependent apoptosis by inhibiting signal transducer and activator of transcription 3 signaling in HER2-overexpressing SKBR3 breast cancer cells
Oxidative Med. Cell. Longev. Souza 2017 1512745 2017 10.1155/2017/1512745 Oxidative stress triggered by apigenin induces apoptosis in a comprehensive panel of human cervical cancer-derived cell lines
Int. J. Oncol. Maeda 52 5 1661 2018 Apigenin induces apoptosis by suppressing Bcl-xl and Mcl-1 simultaneously via signal transducer and activator of transcription 3 signaling in colon cancer
J. Pathol. Glick 221 1 3 2010 10.1002/path.2697 Autophagy: cellular and molecular mechanisms
Cell Mizushima 147 4 728 2011 10.1016/j.cell.2011.10.026 Autophagy: renovation of cells and tissues
Oncogene Singh 37 9 1142 2018 10.1038/s41388-017-0046-6 Dual role of autophagy in hallmarks of cancer
Semin. Cancer Biol. Patra 2020 Autophagy-modulating phytochemicals in cancer therapeutics: current evidences and future perspectives
Cancer Deng 125 8 1228 2019 10.1002/cncr.31978 Targeting autophagy using natural compounds for cancer prevention and therapy
Int. J. Oncol. Lee 44 5 1599 2014 10.3892/ijo.2014.2339 Apigenin-induced apoptosis is enhanced by inhibition of autophagy formation in HCT116 human colon cancer cells
Anti-Cancer Drugs Coelho 27 10 960 2016 10.1097/CAD.0000000000000413 The flavonoid apigenin from Croton betulaster Mull inhibits proliferation, induces differentiation and regulates the inflammatory profile of glioma cells
Mol. Carcinog. Tong 51 3 268 2012 10.1002/mc.20793 Apigenin, a chemopreventive bioflavonoid, induces AMP-activated protein kinase activation in human keratinocytes
Nature Kastan 432 7015 316 2004 10.1038/nature03097 Cell-cycle checkpoints and cancer
Mol. Med. Rep. Fang 12 5 6461 2015 10.3892/mmr.2015.4233 Apigenin inhibits the proliferation of adenoid cystic carcinoma via suppression of glucose transporter-1
Environ. Toxicol. Tseng 32 2 434 2017 10.1002/tox.22247 Inhibition of MDA-MB-231 breast cancer cell proliferation and tumor growth by apigenin through induction of G2/M arrest and histone H3 acetylation-mediated p21(WAF1/CIP1) expression
Oncotarget Meng 8 12 19834 2017 10.18632/oncotarget.15771 Apigenin inhibits renal cell carcinoma cell proliferation
Food Funct. Zhang 6 11 3464 2015 10.1039/C5FO00671F Apigenin induces autophagic cell death in human papillary thyroid carcinoma BCPAP cells
Int. J. Oncol. Maggioni 43 5 1675 2013 10.3892/ijo.2013.2072 Apigenin impairs oral squamous cell carcinoma growth in vitro inducing cell cycle arrest and apoptosis
Nutr. Cancer Solmaz 66 4 599 2014 10.1080/01635581.2014.894099 Therapeutic potential of apigenin, a plant flavonoid, for imatinib-sensitive and resistant chronic myeloid leukemia cells
Oncogene Gupta 21 23 3727 2002 10.1038/sj.onc.1205474 Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells
Development (Cambridge, England) Yu 143 17 3050 2016 10.1242/dev.137075 Proliferation, survival and metabolism: the role of PI3K/AKT/mTOR signalling in pluripotency and cell fate determination
Curr. Opin. Pharmacol. Yap 8 4 393 2008 10.1016/j.coph.2008.08.004 Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promises
Cancer Cell Guertin 12 1 9 2007 10.1016/j.ccr.2007.05.008 Defining the role of mTOR in cancer
Molecules (Basel, Switzerland) Yang 24 8 1584 2019 10.3390/molecules24081584 Brassinin represses invasive potential of lung carcinoma cells through deactivation of PI3K/Akt/mTOR signaling cascade
Curr. Drug Targets Roy 18 4 421 2017 10.2174/1389450117666160307145236 Specific targeting of akt kinase isoforms: taking the precise path for prevention and treatment of cancer
Biomolecules Roy 9 7 253 2019 10.3390/biom9070253 Isoform-specific role of akt in oral squamous cell carcinoma
Cancers Lee 11 2 254 2019 10.3390/cancers11020254 Casticin-induced inhibition of cell growth and survival are mediated through the dual modulation of Akt/mTOR signaling cascade
Int. J. Mol. Sci. Harsha 21 9 3285 2020 10.3390/ijms21093285 Targeting AKT/mTOR in oral cancer: mechanisms and advances in clinical trials
Biochem. Pharmacol. Sethi 76 11 1404 2008 10.1016/j.bcp.2008.05.023 SH-5, an AKT inhibitor potentiates apoptosis and inhibits invasion through the suppression of anti-apoptotic, proliferative and metastatic gene products regulated by IkappaBalpha kinase activation
Nat. Prod. J. Roy 09 3 322 2019 Isoform-specific role of Akt kinase in cancer and its selective targeting by potential anticancer natural agents
PLoS One Mohan 11 4 2016 10.1371/journal.pone.0153155 Trisubstituted-imidazoles induce apoptosis in human breast cancer cells by targeting the oncogenic PI3K/Akt/mTOR signaling pathway
Cell. Signal. Bridgeman 28 5 460 2016 10.1016/j.cellsig.2016.02.008 Inhibition of mTOR by apigenin in UVB-irradiated keratinocytes: a new implication of skin cancer prevention
Carcinogenesis Shukla 35 2 452 2014 10.1093/carcin/bgt316 Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway
Evidence-based Complement. Altern. Med. eCAM Yu 2017 2590676 2017 10.1155/2017/2590676 Apigenin attenuates adriamycin-induced cardiomyocyte apoptosis via the PI3K/AKT/mTOR pathway
Oncol. Rep. Bao 34 4 1805 2015 10.3892/or.2015.4158 Inhibiting GLUT-1 expression and PI3K/Akt signaling using apigenin improves the radiosensitivity of laryngeal carcinoma in vivo
Molecules (Basel, Switzerland) Ko 22 7 1157 2017 10.3390/molecules22071157 2,5-Dihydroxyacetophenone induces apoptosis of multiple myeloma cells by regulating the MAPK activation pathway
Mol. Carcinog. Kim 54 10 1132 2015 10.1002/mc.22184 6-Shogaol exerts anti-proliferative and pro-apoptotic effects through the modulation of STAT3 and MAPKs signaling pathways
Onkologie Hilger 25 6 511 2002 The Ras-Raf-MEK-ERK pathway in the treatment of cancer
Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. Sebolt-Leopold 14 12 3651 2008 10.1158/1078-0432.CCR-08-0333 Advances in the development of cancer therapeutics directed against the RAS-mitogen-activated protein kinase pathway
Biochim. Biophys. Acta McCubrey 1773 8 1263 2007 10.1016/j.bbamcr.2006.10.001 Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
Molecules (Basel, Switzerland) Hasnat 20 12 21157 2015 10.3390/molecules201219752 Apigenin attenuates melanoma cell migration by inducing anoikis through integrin and focal adhesion kinase inhibition
Sci. Rep. Chen 6 2016 Apigenin potentiates TRAIL therapy of non-small cell lung cancer via upregulating DR4/DR5 expression in a p53-dependent manner
Mol. Cancer Ther. Shao 12 12 2640 2013 10.1158/1535-7163.MCT-13-0066 Apigenin sensitizes colon cancer cells to antitumor activity of ABT-263
Pharm. Res. Shukla 29 6 1506 2012 10.1007/s11095-011-0625-0 Apigenin attenuates insulin-like growth factor-I signaling in an autochthonous mouse prostate cancer model
Pancreas Pham 41 8 1306 2012 10.1097/MPA.0b013e31824d64d9 Apigenin inhibits NNK-induced focal adhesion kinase activation in pancreatic cancer cells
J. Cell. Physiol. Lim 231 12 2690 2016 10.1002/jcp.25372 Apigenin reduces survival of choriocarcinoma cells by inducing apoptosis via the PI3K/AKT and ERK1/2 MAPK pathways
Biomedicines Puar 6 3 82 2018 10.3390/biomedicines6030082 Evidence for the involvement of the master transcription factor NF-κB in cancer initiation and progression
Int. J. Mol. Sci. Ramadass 21 14 5164 2020 10.3390/ijms21145164 Small molecule NF-κB pathway inhibitors in clinic
Cancers. Wong 12 8 2020 10.3390/cancers12082203 Targeting NF-κB signaling for multiple myeloma
Cancer Prev. Res. (Phila.) Li 6 8 843 2013 10.1158/1940-6207.CAPR-13-0070 Garcinol, a polyisoprenylated benzophenone modulates multiple proinflammatory signaling cascades leading to the suppression of growth and survival of head and neck carcinoma
Immunol. Rev. Hoffmann 210 171 2006 10.1111/j.0105-2896.2006.00375.x Circuitry of nuclear factor kappaB signaling
Front. Pharmacol. Masuelli 8 373 2017 10.3389/fphar.2017.00373 In vitro and in vivo anti-tumoral effects of the flavonoid apigenin in malignant mesothelioma
FEBS Lett. Akıncılar 589 9 974 2015 10.1016/j.febslet.2015.02.035 Quantitative assessment of telomerase components in cancer cell lines
Trends Pharmacol. Sci. Sethi 30 6 313 2009 10.1016/j.tips.2009.03.004 Potential pharmacological control of the NF-κB pathway
Arch. Toxicol. Li 89 5 711 2015 10.1007/s00204-015-1470-4 NF-κB in cancer therapy
Experim. Biol. Med. (Maywood, N.J.) Sethi 233 1 21 2008 10.3181/0707-MR-196 Nuclear factor-kappaB activation: from bench to bedside
Proc. Natl. Acad. Sci. U. S. A. Li 113 50 14402 2016 10.1073/pnas.1611106113 Activation of mutant TERT promoter by RAS-ERK signaling is a key step in malignant progression of BRAF-mutant human melanomas
Crit. Rev. Immunol. Kunnumakkara 40 1 1 2020 10.1615/CritRevImmunol.2020033210 Inflammation, NF-κB, and chronic diseases: how are they linked?
Kunnumakkara 177 2009 Drug Resistance in Cancer Cells Nuclear factor-κB and chemoresistance: how intertwined are they?
J. Transl. Med. Kunnumakkara 16 1 14 2018 10.1186/s12967-018-1381-2 Chronic diseases, inflammation, and spices: how are they linked?
Cancer Res. Kunnumakkara 67 8 3853 2007 10.1158/0008-5472.CAN-06-4257 Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products
Nat. Commun. Khattar 10 1 5349 2019 10.1038/s41467-019-13082-9 Rap1 regulates hematopoietic stem cell survival and affects oncogenesis and response to chemotherapy
Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. Lin 13 11 3423 2007 10.1158/1078-0432.CCR-06-3072 Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway
Cell. Microbiol. Iyer 10 7 1442 2008 10.1111/j.1462-5822.2008.01137.x Probiotic Lactobacillus reuteri promotes TNF-induced apoptosis in human myeloid leukemia-derived cells by modulation of NF-kappaB and MAPK signalling
Antioxidants (Basel, Switzerland) Ozturk 6 1 17 2017 Current insights to regulation and role of telomerase in human diseases
Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. Kunnumakkara 14 7 2128 2008 10.1158/1078-0432.CCR-07-4722 Curcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear factor-kappaB-regulated gene products
J. Biol. Chem. Pandey 282 24 17340 2007 10.1074/jbc.M700890200 Butein, a tetrahydroxychalcone, inhibits nuclear factor (NF)-kappaB and NF-kappaB-regulated gene expression through direct inhibition of IkappaBalpha kinase beta on cysteine 179 residue
Cancer Res. Pandey 68 13 5370 2008 10.1158/0008-5472.CAN-08-0511 Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis
Curr. Drug Targets Monisha 18 2 232 2017 10.2174/1389450117666160201112330 Nuclear factor kappa B: a potential target to persecute head and neck cancer
PLoS One Shukla 10 9 2015 10.1371/journal.pone.0138710 Suppression of NF-κB and NF-κB-regulated gene expression by apigenin through IκBα and IKK pathway in TRAMP mice
Front. Oncol. Loh 9 48 2019 10.3389/fonc.2019.00048 Signal transducer and activator of transcription (STATs) proteins in cancer and inflammation: functions and therapeutic implication
Cancers Arora 10 9 327 2018 10.3390/cancers10090327 The role of signal transducer and activator of transcription 3 (STAT3) and its targeted inhibition in hematological malignancies
Br. J. Cancer Siveen 111 7 1327 2014 10.1038/bjc.2014.422 Negative regulation of signal transducer and activator of transcription-3 signalling cascade by lupeol inhibits growth and induces apoptosis in hepatocellular carcinoma cells
Mol. Carcinog. Kim 53 10 793 2014 10.1002/mc.22035 β-Caryophyllene oxide inhibits constitutive and inducible STAT3 signaling pathway through induction of the SHP-1 protein tyrosine phosphatase
J. Cell Sci. Rawlings 117 Pt 8 1281 2004 10.1242/jcs.00963 The JAK/STAT signaling pathway
Oncotarget Lee 8 11 17700 2017 10.18632/oncotarget.10775 Capsazepine inhibits JAK/STAT3 signaling, tumor growth, and cell survival in prostate cancer
Int. J. Oncol. Khanna 47 5 1617 2015 10.3892/ijo.2015.3160 The JAK/STAT signaling cascade in gastric carcinoma (review)
Mol. Oncol. Dai 9 4 818 2015 10.1016/j.molonc.2014.12.008 Ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting STAT3 signaling cascade through the induction of PIAS3
Vaccines Mullen 4 3 26 2016 10.3390/vaccines4030026 Leptin-induced JAK/STAT signaling and cancer growth
Ann. N. Y. Acad. Sci. Aggarwal 1171 59 2009 10.1111/j.1749-6632.2009.04911.x Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?
Cancer Lett. Lee 345 1 140 2014 10.1016/j.canlet.2013.12.008 Capillarisin inhibits constitutive and inducible STAT3 activation through induction of SHP-1 and SHP-2 tyrosine phosphatases
Ann. N. Y. Acad. Sci. Aggarwal 1091 151 2006 10.1196/annals.1378.063 Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution
Oncotarget Lee 6 8 6386 2015 10.18632/oncotarget.3443 Brassinin inhibits STAT3 signaling pathway through modulation of PIAS-3 and SOCS-3 expression and sensitizes human lung cancer xenograft in nude mice to paclitaxel
Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. Bhutani 13 10 3024 2007 10.1158/1078-0432.CCR-06-2575 Capsaicin is a novel blocker of constitutive and interleukin-6-inducible STAT3 activation
Int. J. Oncol. Suh 46 3 1405 2015 10.3892/ijo.2014.2808 Inhibition of IL-6/STAT3 axis and targeting Axl and Tyro3 receptor tyrosine kinases by apigenin circumvent taxol resistance in ovarian cancer cells
Br. J. Pharmacol. Ong 174 24 4684 2017 10.1111/bph.13958 Lnc'-ing Wnt in female reproductive cancers: therapeutic potential of long non-coding RNAs in Wnt signalling
Cancers Bhuvanalakshmi 11 1 25 2018 10.3390/cancers11010025 Stemness, pluripotentiality, and Wnt antagonism: sFRP4, a Wnt antagonist mediates pluripotency and stemness in glioblastoma
Acta Physiol. (Oxford, England) Archbold 204 1 74 2012 10.1111/j.1748-1716.2011.02293.x How do they do Wnt they do?: regulation of transcription by the Wnt/β-catenin pathway
Cell. Signal. Krausova 26 3 570 2014 10.1016/j.cellsig.2013.11.032 Wnt signaling in adult intestinal stem cells and cancer
Biochim. Biophys. Acta Giles 1653 1 1 2003 Caught up in a Wnt storm: Wnt signaling in cancer
Cell Tissue Res. Ahmadzadeh 363 2 321 2016 10.1007/s00441-015-2300-y Wnt/β-catenin signaling in bone marrow niche
Oncogenesis Pohl 6 4 e310 2017 10.1038/oncsis.2017.14 Wnt signaling in triple-negative breast cancer
Front. Pharmacol. Bhuvanalakshmi 8 124 2017 10.3389/fphar.2017.00124 Breast cancer stem-like cells are inhibited by diosgenin, a steroidal saponin, by the attenuation of the Wnt β-catenin signaling via the Wnt antagonist secreted frizzled related protein-4
Oncol. Lett. Xu 11 5 3075 2016 10.3892/ol.2016.4331 Apigenin suppresses colorectal cancer cell proliferation, migration and invasion via inhibition of the Wnt/β-catenin signaling pathway
Sci. Rep. Lin 7 1 372 2017 10.1038/s41598-017-00409-z Apigenin-induced lysosomal degradation of β-catenin in Wnt/β-catenin signaling
Biomolecules Chen 10 1 66 2019 10.3390/biom10010066 The emerging role of long non-coding RNAs in the metastasis of hepatocellular carcinoma
Trends Mol. Med. Chew 24 1 66 2018 10.1016/j.molmed.2017.11.003 Noncoding rnas: master regulators of inflammatory signaling
Cells Cheng 8 10 1178 2019 10.3390/cells8101178 Insights into biological role of LncRNAs in epithelial-mesenchymal transition
Carcinogenesis Romano 38 5 485 2017 10.1093/carcin/bgx026 Small non-coding RNA and cancer
Nat. Rev. Cancer Anastasiadou 18 1 5 2018 10.1038/nrc.2017.99 Non-coding RNA networks in cancer
Cell. Mol. Life Sci. CMLS Mishra 76 10 1947 2019 10.1007/s00018-019-03053-0 Long non-coding RNAs are emerging targets of phytochemicals for cancer and other chronic diseases
J. Hepatol. Klingenberg 67 3 603 2017 10.1016/j.jhep.2017.04.009 Non-coding RNA in hepatocellular carcinoma: mechanisms, biomarkers and therapeutic targets
Int. J. Biochem. Cell Biol. Ma 108 17 2019 10.1016/j.biocel.2019.01.003 The expanding roles of long non-coding RNAs in the regulation of cancer stem cells
Mol. Med. Rep. Chen 14 3 2352 2016 10.3892/mmr.2016.5460 Apigenin inhibits glioma cell growth through promoting microRNA-16 and suppression of BCL-2 and nuclear factor-κB/MMP-9
Chem. Biol. Interact. Gao 280 45 2018 10.1016/j.cbi.2017.11.020 Apigenin sensitizes hepatocellular carcinoma cells to doxorubic through regulating miR-520b/ATG7 axis
Oncotarget Gao 8 47 82085 2017 10.18632/oncotarget.18294 Apigenin sensitizes BEL-7402/ADM cells to doxorubicin through inhibiting miR-101/Nrf2 pathway
Cancer Genom. Proteom. Bauer 16 6 421 2019 10.21873/cgp.20146 Whole transcriptomic analysis of apigenin on TNFα immuno-activated MDA-MB-231 breast cancer cells
Oncol. Lett. Bauer 19 3 2123 2020 Effect of apigenin on whole transcriptome profile of TNFα-activated MDA-MB-468 triple negative breast cancer cells
J. Clin. Pathol. Marchiò 63 3 220 2010 10.1136/jcp.2009.073908 Adenoid cystic carcinomas of the breast and salivary glands (or ‘the strange case of Dr Jekyll and Mr Hyde’ of exocrine gland carcinomas)
Int. J. Surg. Pathol. Fusco 23 1 26 2015 10.1177/1066896914548795 The birth of an adenoid cystic carcinoma
J. Steroid Biochem. Mol. Biol. Else 165 Pt A 109 2017 10.1016/j.jsbmb.2016.03.008 Adrenocortical carcinoma in a 17th-century girl
Toxicol. Sci. Off. J. Soc. Toxicol. Sanderson 82 1 70 2004 10.1093/toxsci/kfh257 Induction and inhibition of aromatase (CYP19) activity by natural and synthetic flavonoid compounds in H295R human adrenocortical carcinoma cells
Nat. Rev. Dis. Prim. Sanli 3 2017 Bladder cancer
Int. J. Cancer Ferlay 136 5 E359 2015 10.1002/ijc.29210 Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012
Roy 51 2017 Bladder Cancer: Chemoresistance and Chemosensitization, Cancer Cell Chemoresistance and Chemosensitization
J. Agric. Food Chem. Xia 66 29 7663 2018 10.1021/acs.jafc.8b02351 Apigenin suppresses the IL-1β-induced expression of the urokinase-type plasminogen activator receptor by inhibiting MAPK-mediated AP-1 and NF-κB signaling in human bladder cancer T24 cells
Drug Chem. Toxicol. Kilani-Jaziri 35 1 1 2012 10.3109/01480545.2011.564180 Flavones inhibit the proliferation of human tumor cancer cell lines by inducing apoptosis
Cancer Cell Int. Zhu 13 1 54 2013 10.1186/1475-2867-13-54 Apigenin promotes apoptosis, inhibits invasion and induces cell cycle arrest of T24 human bladder cancer cells
Biocell Off. J. Soc. Latinoamericanas Microscopia Electronica et. al. Liu 35 3 71 2011 Apigenin inhibits cell migration through MAPK pathways in human bladder smooth muscle cells
Cancer Treat. Rev. Wang 62 29 2018 10.1016/j.ctrv.2017.10.014 Triple negative breast cancer in Asia: an insider's view
Clinical Breast Cancer Thakur 18 3 e393 2018 10.1016/j.clbc.2017.07.013 Alarming burden of triple-negative breast cancer in India
Alkabban 2020 Breast Cancer
Anti-Cancer Drugs Jia 27 3 147 2016 10.1097/CAD.0000000000000328 Potential role of targeted therapies in the treatment of triple-negative breast cancer
Front. Pharmacol. Shanmugam 9 1294 2018 10.3389/fphar.2018.01294 Thymoquinone inhibits bone metastasis of breast cancer cells through abrogation of the CXCR4 signaling axis
J. Adv. Pharm. Technol. Res. Sharma 1 2 109 2010 Various types and management of breast cancer: an overview
J. Cell. Biochem. Liu 120 3 4504 2019 10.1002/jcb.27738 Oleuropein induces apoptosis via abrogating NF-κB activation cascade in estrogen receptor-negative breast cancer cells
Anti Cancer Agents Med. Chem. Nabavi 15 6 728 2015 10.2174/1871520615666150304120643 Apigenin and breast cancers: from chemistry to medicine
Res. Commun. Chem. Pathol. Pharmacol. Hirano 64 1 69 1989 Antiproliferative effects of synthetic and naturally occurring flavonoids on tumor cells of the human breast carcinoma cell line, ZR-75-1
Mol. Nutr. Food Res. Khan 58 3 437 2014 10.1002/mnfr.201300417 Plant polyphenol induced cell death in human cancer cells involves mobilization of intracellular copper ions and reactive oxygen species generation: a mechanism for cancer chemopreventive action
Cell Death Discov. Li 4 105 2018 10.1038/s41420-018-0124-8 Apigenin suppresses the stem cell-like properties of triple-negative breast cancer cells by inhibiting YAP/TAZ activity
Front. Pharmacol. Hong 9 220 2018 10.3389/fphar.2018.00220 Apigenin and luteolin attenuate the breaching of MDA-MB231 breast cancer spheroids through the lymph endothelial barrier in vitro
Oncol. Rep. Seo 38 2 715 2017 10.3892/or.2017.5752 Apigenin overcomes drug resistance by blocking the signal transducer and activator of transcription 3 signaling in breast cancer cells
Naunyn Schmiedeberg's Arch. Pharmacol. Vrhovac Madunić 391 5 537 2018 10.1007/s00210-018-1486-4 Apigenin, a dietary flavonoid, induces apoptosis, DNA damage, and oxidative stress in human breast cancer MCF-7 and MDA MB-231 cells
PLoS One Bauer 12 4 2017 10.1371/journal.pone.0175558 Apigenin inhibits TNFα/IL-1α-induced CCL2 release through IKBK-epsilon signaling in MDA-MB-231 human breast cancer cells
GeroScience Perrott 39 2 161 2017 10.1007/s11357-017-9970-1 Apigenin suppresses the senescence-associated secretory phenotype and paracrine effects on breast cancer cells
Cancer Lett. Coombs 380 2 424 2016 10.1016/j.canlet.2016.06.023 Apigenin inhibits the inducible expression of programmed death ligand 1 by human and mouse mammary carcinoma cells
J. Agric. Food Chem. Huang 64 21 4235 2016 10.1021/acs.jafc.6b00766 Chrysin, abundant in Morinda citrifolia fruit water-EtOAc extracts, combined with apigenin synergistically induced apoptosis and inhibited migration in human breast and liver cancer cells
BMC Cancer Lin 15 958 2015 10.1186/s12885-015-1965-7 Flavones inhibit breast cancer proliferation through the Akt/FOXO3a signaling pathway
Oncol. Lett. Liu 13 2 1024 2017 10.3892/ol.2016.5495 Apigenin enhances the cisplatin cytotoxic effect through p53-modulated apoptosis
Int. J. Oncol. Weldon 26 3 763 2005 PKC-mediated survival signaling in breast carcinoma cells: a role for MEK1-AP1 signaling
J. Biol. Chem. Way 279 6 4479 2004 10.1074/jbc.M305529200 Apigenin induces apoptosis through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway
Anticancer Res. Yin 21 1a 413 2001 Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells
Mol. Cell. Biochem. Seo 366 1-2 319 2012 10.1007/s11010-012-1310-2 Apigenin induces apoptosis via extrinsic pathway, inducing p53 and inhibiting STAT3 and NFκB signaling in HER2-overexpressing breast cancer cells
Anticancer Res. Seo 34 6 2869 2014 Induction of caspase-dependent apoptosis by apigenin by inhibiting STAT3 signaling in HER2-overexpressing MDA-MB-453 breast cancer cells
FEBS Lett. Way 579 1 145 2005 10.1016/j.febslet.2004.11.061 Degradation of HER2/neu by apigenin induces apoptosis through cytochrome c release and caspase-3 activation in HER2/neu-overexpressing breast cancer cells
Exp. Mol. Pathol. Harrison 97 2 211 2014 10.1016/j.yexmp.2014.07.006 Exposure of breast cancer cells to a subcytotoxic dose of apigenin causes growth inhibition, oxidative stress, and hypophosphorylation of Akt
Acta Nat. Scherbakov 7 3 133 2015 10.32607/20758251-2015-7-3-133-139 Apigenin inhibits growth of breast cancer cells: the role of ERα and HER2/neu
Scanning Bai 36 6 622 2014 10.1002/sca.21170 Apigenin induced MCF-7 cell apoptosis-associated reactive oxygen species
Toxicol. Appl. Pharmacol. Lecomte 325 61 2017 10.1016/j.taap.2017.04.005 Assessment of the potential activity of major dietary compounds as selective estrogen receptor modulators in two distinct cell models for proliferation and differentiation
Zhongguo Zhong Yao Za Zhi Zhongguo Zhongyao Zazhi China J. Chin. Mater. Med. Zhu 37 15 2317 2012 Study on estrogenic effect of genistein and apigenin in vitro
Food Chem. Toxicol. Int. J. Brit. Ind. Biol. Res. Assoc. Lau 48 10 3022 2010 10.1016/j.fct.2010.07.046 The dietary flavonoid apigenin blocks phorbol 12-myristate 13-acetate-induced COX-2 transcriptional activity in breast cell lines
Menopause (New York, N.Y.) Mafuvadze 17 5 1055 2010 10.1097/gme.0b013e3181dd052f Apigenin blocks induction of vascular endothelial growth factor mRNA and protein in progestin-treated human breast cancer cells
Oncol. Rep. Noh 24 1 277 2010 Suppression of phorbol-12-myristate-13-acetate-induced tumor cell invasion by apigenin via the inhibition of p38 mitogen-activated protein kinase-dependent matrix metalloproteinase-9 expression
Breast Cancer Res. BCR Chen 9 6 R80 2007 10.1186/bcr1797 Inhibition of proteasome activity by the dietary flavonoid apigenin is associated with growth inhibition in cultured breast cancer cells and xenografts
Nutr. Cancer Lindenmeyer 39 1 139 2001 10.1207/S15327914nc391_19 Apigenin acts on the tumor cell invasion process and regulates protease production
J. Nutr. Biochem. Choi 20 4 285 2009 10.1016/j.jnutbio.2008.03.005 Apigenin causes G(2)/M arrest associated with the modulation of p21(Cip1) and Cdc2 and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 cells
J. Clin. Biochem. Nutr. Choi 44 3 260 2009 10.3164/jcbn.08-230 Apigenin induces apoptosis through a mitochondria/caspase-pathway in human breast cancer MDA-MB-453 cells
Nutrients Lecomte 11 2 237 2019 10.3390/nu11020237 Deciphering the molecular mechanisms sustaining the estrogenic activity of the two major dietary compounds zearalenone and apigenin in er-positive breast cancer cell lines
Mol. Cancer Ther. Long 7 7 2096 2008 10.1158/1535-7163.MCT-07-2350 Apigenin inhibits antiestrogen-resistant breast cancer cell growth through estrogen receptor-alpha-dependent and estrogen receptor-alpha-independent mechanisms
Breast Cancer Res. Treat. Seo 99 2 121 2006 10.1007/s10549-006-9191-2 Stimulatory effect of genistein and apigenin on the growth of breast cancer cells correlates with their ability to activate ER alpha
Neoplasia (New York, N.Y.) Mak 8 11 896 2006 10.1593/neo.06538 Apigenin suppresses cancer cell growth through ERbeta
Nutr. Cancer Mafuvadze 65 8 1184 2013 10.1080/01635581.2013.833637 Effects of dietary apigenin on tumor latency, incidence and multiplicity in a medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced breast cancer model
Lancet (London, England) Cohen 393 10167 169 2019 10.1016/S0140-6736(18)32470-X Cervical cancer
Kumar 718 2007 Robbins Basic Pathology
Pharmacol. Res. Banik 153 2020 10.1016/j.phrs.2020.104635 Piceatannol: a natural stilbene for the prevention and treatment of cancer
Banik 163 2018 Potential of Different Chemosensitizers to Overcome Chemoresistance in Cervical Cancer, Cancer Cell Chemoresistance and Chemosensitization
Apoptosis Int. J. Programmed Cell Death Ningegowda 22 1 145 2017 10.1007/s10495-016-1312-8 A novel 4,6-disubstituted-1,2,4-triazolo-1,3,4-thiadiazole derivative inhibits tumor cell invasion and potentiates the apoptotic effect of TNFα by abrogating NF-κB activation cascade
Molecules (Basel, Switzerland) Zhang 25 8 2020 10.3390/molecules25081960 Apigenin inhibits histamine-induced cervical cancer tumor growth by regulating estrogen receptor expression
Oncotarget Yang 8 28 46145 2017 10.18632/oncotarget.17574 Bioinformatics and in vitro experimental analyses identify the selective therapeutic potential of interferon gamma and apigenin against cervical squamous cell carcinoma and adenocarcinoma
Int. J. Cancer Czyz 114 1 12 2005 10.1002/ijc.20620 Flavonoid apigenin inhibits motility and invasiveness of carcinoma cells in vitro
Mol. Med. Rep. Liu 11 1 665 2015 10.3892/mmr.2014.2720 Apigenin inhibits HeLa sphere-forming cells through inactivation of casein kinase 2α
Life Sci. Zheng 76 12 1367 2005 10.1016/j.lfs.2004.08.023 Apigenin induced apoptosis through p53-dependent pathway in human cervical carcinoma cells
PLoS One Xu 6 12 2011 10.1371/journal.pone.0029169 Synergistic effects of apigenin and paclitaxel on apoptosis of cancer cells
Nat. Rev. Dis. Prim. Kuipers 1 2015 Colorectal cancer
Nutrients Buhrmann 11 3 704 2019 10.3390/nu11030704 Induction of the epithelial-to-mesenchymal transition of human colorectal cancer by human TNF-β (Lymphotoxin) and its reversal by resveratrol
Nutrients Buhrmann 11 12 2904 2019 10.3390/nu11122904 Evidence that Calebin A, a component of Curcuma longa suppresses NF-B mediated proliferation, invasion and metastasis of human colorectal cancer induced by TNF-β (Lymphotoxin)
Int. J. Mol. Sci. Buhrmann 21 7 2393 2020 10.3390/ijms21072393 Calebin a potentiates the effect of 5-FU and TNF-β (Lymphotoxin α) against human colorectal cancer cells: potential role of NF-κB
Biomedicines. Buhrmann 8 8 2020 10.3390/biomedicines8080236 Targeting NF-κB signaling by Calebin A, a compound of turmeric, in multicellular tumor microenvironment: potential role of apoptosis induction in CRC cells
Int. J. Cancer Kunnumakkara 125 9 2187 2009 10.1002/ijc.24593 Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model
Curr. Colorectal Cancer Rep. Kunnumakkara 5 1 5 2009 10.1007/s11888-009-0002-0 Curcumin and colorectal cancer: add spice to your life
Oncotarget Ai 8 59 100216 2017 10.18632/oncotarget.22145 Apigenin inhibits colonic inflammation and tumorigenesis by suppressing STAT3-NF-κB signaling
J. Agric. Food Chem. Shan 65 37 8136 2017 10.1021/acs.jafc.7b02757 Apigenin restrains colon cancer cell proliferation via targeted blocking of pyruvate kinase M2-dependent glycolysis
J. Nutr. Biochem. Chunhua 24 10 1766 2013 10.1016/j.jnutbio.2013.03.006 Apigenin up-regulates transgelin and inhibits invasion and migration of colorectal cancer through decreased phosphorylation of AKT
J. B.U.ON. Off. J. Balkan Union Oncol. Chen 24 2 488 2019 Apigenin inhibits in vitro and in vivo tumorigenesis in cisplatin-resistant colon cancer cells by inducing autophagy, programmed cell death and targeting m-TOR/PI3K/Akt signalling pathway
Nat. Prod. Res. Hamadou 1 2019 Apigenin rich-Limonium duriusculum (de Girard) Kuntze promotes apoptosis in HCT116 cancer cells
Mol. Carcinog. Wang 28 2 102 2000 10.1002/1098-2744(200006)28:2<102::AID-MC6>3.0.CO;2-2 Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines
Nutr. Cancer Wang 48 1 106 2004 10.1207/s15327914nc4801_14 Individual and interactive effects of apigenin analogs on G2/M cell-cycle arrest in human colon carcinoma cell lines
Mol. Carcinog. Chung 46 9 773 2007 10.1002/mc.20306 Impact of adenomatous polyposis coli (APC) tumor supressor gene in human colon cancer cell lines on cell cycle arrest by apigenin
PLoS One Iizumi 8 8 2013 10.1371/journal.pone.0073219 The flavonoid apigenin downregulates CDK1 by directly targeting ribosomal protein S9
Redox Biol. Banerjee 5 153 2015 10.1016/j.redox.2015.04.009 Oxidative stress triggered by naturally occurring flavone apigenin results in senescence and chemotherapeutic effect in human colorectal cancer cells
Toxicol. Appl. Pharmacol. Dai 311 106 2016 10.1016/j.taap.2016.09.016 Downregulation of NEDD9 by apigenin suppresses migration, invasion, and metastasis of colorectal cancer cells
Toxicol. Appl. Pharmacol. Wang 272 1 108 2013 10.1016/j.taap.2013.05.028 Apigenin suppresses migration and invasion of transformed cells through down-regulation of C-X-C chemokine receptor 4 expression
Evidence-based Complement. Altern. Med. eCAM Wang 2017 3684581 2017 Apigenin inhibits human SW620 cell growth by targeting polyamine catabolism
Clin. Experim. Metastasis Lefort 28 4 337 2011 10.1007/s10585-010-9364-6 The dietary flavonoid apigenin enhances the activities of the anti-metastatic protein CD26 on human colon carcinoma cells
Biosci. Rep. Tong 39 5 2019 10.1042/BSR20190452 Apigenin inhibits epithelial-mesenchymal transition of human colon cancer cells through NF-κB/snail signaling pathway
Oncol. Lett. Wang 2 1 43 2011 10.3892/ol.2010.215 Apigenin suppresses the growth of colorectal cancer xenografts via phosphorylation and up-regulated FADD expression
Eur. J. Cancer (Oxford, England: 1990) Zhong 46 18 3365 2010 10.1016/j.ejca.2010.07.007 Molecular targets of apigenin in colorectal cancer cells: involvement of p21, NAG-1 and p53
Int. J. Oncol. Takagaki 26 1 185 2005 Apigenin induces cell cycle arrest and p21/WAF1 expression in a p53-independent pathway
Experim. Biol. Med. (Maywood, N.J.) Leonardi 235 6 710 2010 10.1258/ebm.2010.009359 Apigenin and naringenin suppress colon carcinogenesis through the aberrant crypt stage in azoxymethane-treated rats
Am. J. Physiol. Gastrointest. Liver Physiol. Farah 285 5 G919 2003 10.1152/ajpgi.00205.2003 5,6-Dichloro-ribifuranosylbenzimidazole- and apigenin-induced sensitization of colon cancer cells to TNF-alpha-mediated apoptosis
Am. Fam. Physician Short 95 1 22 2017 Esophageal cancer
Bordoloi 241 2018 Different Approaches to Overcome Chemoresistance in Esophageal Cancer, Cancer Cell Chemoresistance and Chemosensitization
Scanning Zhu 38 4 322 2016 10.1002/sca.21273 Apigenin induced apoptosis in esophageal carcinoma cells by destruction membrane structures
Front. Pharmacol. Qiu 10 1002 2019 10.3389/fphar.2019.01002 Apigenin inhibits IL-6 transcription and suppresses esophageal carcinogenesis
Toxicol. In Vitro Int. J. Assoc. BIBRA Zhang 23 5 797 2009 10.1016/j.tiv.2009.04.007 Cytotoxicity of flavones and flavonols to a human esophageal squamous cell carcinoma cell line (KYSE-510) by induction of G2/M arrest and apoptosis
Cancer Metastasis Rev Sexton 39 1179 2020 10.1007/s10555-020-09925-3 Gastric cancer: a comprehensive review of current and future treatment strategies
Cancer Lett. Manu 363 1 28 2015 10.1016/j.canlet.2015.03.033 Isorhamnetin augments the anti-tumor effect of capecitabine through the negative regulation of NF-κB signaling cascade in gastric cancer
Choudhary 267 2017 Different Chemosensitization Approaches in Gastric Cancer, Cancer Cell Chemoresistance and Chemosensitization
J. Mol. Med. (Berlin, Germany) Manu 92 3 267 2014 10.1007/s00109-013-1095-0 Simvastatin sensitizes human gastric cancer xenograft in nude mice to capecitabine by suppressing nuclear factor-kappa B-regulated gene products
Tumour Biol. J. Int. Soc. Oncodev. Biol. Med. Chen 35 8 7719 2014 10.1007/s13277-014-2014-x The apoptotic effect of apigenin on human gastric carcinoma cells through mitochondrial signal pathway
World J. Gastroenterol. Wu 11 29 4461 2005 10.3748/wjg.v11.i29.4461 Inhibitory effects of apigenin on the growth of gastric carcinoma SGC-7901 cells
J. Neuro-Oncol. Bleeker 108 1 11 2012 10.1007/s11060-011-0793-0 Recent advances in the molecular understanding of glioblastoma
Khwairakpam 107 2017 Chemoresistance in Brain Cancer and Different Chemosensitization Approaches, Cancer Cell Chemoresistance and Chemosensitization
Food Chem. Toxicol. Int. J. Brit. Ind. Biol. Res. Assoc. Seibert 49 9 2398 2011 10.1016/j.fct.2011.06.055 Cytoprotective activity against peroxide-induced oxidative damage and cytotoxicity of flavonoids in C6 rat glioma cells
Tumour Biol. J. Int. Soc. Oncodevelop. Biol. Med. Wan 39 4 2017 miR-423-5p knockdown enhances the sensitivity of glioma stem cells to apigenin through the mitochondrial pathway
J. Pharm. Pharmacol. Stump 69 7 907 2017 10.1111/jphp.12718 The antiproliferative and apoptotic effects of apigenin on glioblastoma cells
Biochem. Biophys. Res. Commun. Sato 204 2 578 1994 10.1006/bbrc.1994.2498 Apigenin induces morphological differentiation and G2-M arrest in rat neuronal cells
Phytother. Res. PTR Kim 30 11 1833 2016 10.1002/ptr.5689 Apigenin inhibits cancer stem cell-like phenotypes in human glioblastoma cells via suppression of c-Met signaling
Chem. Biol. Interact. Santos 242 123 2015 10.1016/j.cbi.2015.07.014 Flavonoids suppress human glioblastoma cell growth by inhibiting cell metabolism, migration, and by regulating extracellular matrix proteins and metalloproteinases expression
Cancer Das 116 1 164 2010 10.1002/cncr.24699 Flavonoids activated caspases for apoptosis in human glioblastoma T98G and U87MG cells but not in human normal astrocytes
Nat. Rev. Clin. Oncol. Cramer 16 11 669 2019 10.1038/s41571-019-0227-z The changing therapeutic landscape of head and neck cancer
Phytomed. Int. J. Phytother. Phytopharmacol. Baek 23 5 566 2016 Resveratrol inhibits STAT3 signaling pathway through the induction of SOCS-1: role in apoptosis induction and radiosensitization in head and neck tumor cells
Thakur 399 2017 Different Chemosensitization Approaches for the Effective Management of HNSCC, Cancer Cell Chemoresistance and Chemosensitization
Oncotarget Li 6 7 5147 2015 10.18632/oncotarget.2881 Garcinol sensitizes human head and neck carcinoma to cisplatin in a xenograft mouse model despite downregulation of proliferative biomarkers
Oncotarget Selvi 6 41 43806 2015 10.18632/oncotarget.6245 Inhibition of p300 lysine acetyltransferase activity by luteolin reduces tumor growth in head and neck squamous cell carcinoma (HNSCC) xenograft mouse model
Arch. Oral Biol. Ketkaew 74 69 2017 10.1016/j.archoralbio.2016.11.010 Apigenin inhibited hypoxia induced stem cell marker expression in a head and neck squamous cell carcinoma cell line
Biochim. Biophys. Acta Chan 1820 7 1081 2012 10.1016/j.bbagen.2012.04.013 Apigenin induces apoptosis via tumor necrosis factor receptor- and Bcl-2-mediated pathway and enhances susceptibility of head and neck squamous cell carcinoma to 5-fluorouracil and cisplatin
Front. Biosci. (Landmark Edit.) Masuelli 16 1060 2011 10.2741/3735 Apigenin induces apoptosis and impairs head and neck carcinomas EGFR/ErbB2 signaling
Oral Surg Oral Med Oral Pathol Oral Radiol Swanson 117 2 214 2014 10.1016/j.oooo.2013.10.012 Impact of apigenin and kaempferol on human head and neck squamous cell carcinoma
Med. Oral Patol. Oral Cirugia Bucal Dhanuthai 23 1 e23 2018 Oral cancer: a multicenter study
Cancers Monisha 10 7 228 2018 10.3390/cancers10070228 NGAL is downregulated in oral squamous cell carcinoma and leads to increased survival, proliferation, migration and chemoresistance
Asian Pac. J. Cancer Prevent. APJCP Bordoloi 20 11 3437 2019 10.31557/APJCP.2019.20.11.3437 An investigation on the therapeutic potential of butein, a tretrahydroxychalcone against human oral squamous cell carcinoma
Eur. J. Pharmacol. Silvan 670 2-3 571 2011 10.1016/j.ejphar.2011.09.179 Chemopreventive potential of apigenin in 7,12-dimethylbenz(a)anthracene induced experimental oral carcinogenesis
Arch. Oral Biol. Baldasquin-Caceres 59 10 1101 2014 10.1016/j.archoralbio.2014.06.007 Chemopreventive potential of phenolic compounds in oral carcinogenesis
Anticancer Res. Yin 19 5b 4297 1999 Signal pathways involved in apigenin inhibition of growth and induction of apoptosis of human anaplastic thyroid cancer cells (ARO)
Mol. Cell. Endocrinol. Kim 369 1-2 130 2013 10.1016/j.mce.2013.01.012 Apigenin induces c-Myc-mediated apoptosis in FRO anaplastic thyroid carcinoma cells
J. Endocrinol. Investig. Kim 36 11 1099 2013 Akt inhibition enhances the cytotoxic effect of apigenin in combination with PLX4032 in anaplastic thyroid carcinoma cells harboring BRAFV600E
Thyroid Off. J. Am. Thyroid Assoc. Lakshmanan 24 5 878 2014 10.1089/thy.2013.0614 Apigenin in combination with Akt inhibition significantly enhances thyrotropin-stimulated radioiodide accumulation in thyroid cells
Oncotarget Lakshmanan 6 31 31792 2015 10.18632/oncotarget.5172 Modulation of thyroidal radioiodide uptake by oncological pipeline inhibitors and Apigenin
Int. J. Clin. Exp. Pathol. Xu 7 7 3938 2014 Apigenin suppresses GLUT-1 and p-AKT expression to enhance the chemosensitivity to cisplatin of laryngeal carcinoma Hep-2 cells: an in vitro study
Biosci. Rep. Zhang 38 3 2018 10.1042/BSR20180456 Apigenin inhibits C5a-induced proliferation of human nasopharyngeal carcinoma cells through down-regulation of C5aR
Biomed. Pharmacother. Biomed. Pharmacother. Hu 102 681 2018 10.1016/j.biopha.2018.03.111 Apigenin enhances the antitumor effects of cetuximab in nasopharyngeal carcinoma by inhibiting EGFR signaling
Progress Tumor Res. Juliusson 43 87 2016 10.1159/000447076 Leukemia
Eur. J. Nutr. Nakazaki 52 1 25 2013 10.1007/s00394-011-0282-4 Proteomic study of granulocytic differentiation induced by apigenin 7-glucoside in human promyelocytic leukemia HL-60 cells
Food Chem. Toxicol. Int. J. Brit. Ind. Biol. Res. Assoc. Jayasooriya 50 8 2605 2012 10.1016/j.fct.2012.05.024 Apigenin decreases cell viability and telomerase activity in human leukemia cell lines
Arch. Biochem. Biophys. Miyoshi 466 2 274 2007 10.1016/j.abb.2007.07.026 Dietary flavonoid apigenin is a potential inducer of intracellular oxidative stress: the role in the interruptive apoptotic signal
Eur. J. Cancer (Oxford, England 1990) Wang 35 10 1517 1999 10.1016/S0959-8049(99)00168-9 Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukaemia HL-60 cells
Biochem. Pharmacol. Vargo 72 6 681 2006 10.1016/j.bcp.2006.06.010 Apigenin-induced-apoptosis is mediated by the activation of PKCdelta and caspases in leukemia cells
Acta Med. Iran. Hashemi 48 5 283 2010 Anti-mutagenic and pro-apoptotic effects of apigenin on human chronic lymphocytic leukemia cells
Target. Oncol. Swamy 12 1 1 2017 10.1007/s11523-016-0452-7 Targeting multiple oncogenic pathways for the treatment of hepatocellular carcinoma
Singh 373 2017 Different Methods to Inhibit Chemoresistance in Hepatocellular Carcinoma, Cancer Cell Chemoresistance and Chemosensitization
Cancers Raghunath 10 12 481 2018 10.3390/cancers10120481 Dysregulation of Nrf2 in hepatocellular carcinoma: role in cancer progression and chemoresistance
J. Biol. Chem. Mohan 289 49 34296 2014 10.1074/jbc.M114.601104 Development of a novel azaspirane that targets the Janus kinase-signal transducer and activator of transcription (STAT) pathway in hepatocellular carcinoma in vitro and in vivo
Mol. Cancer Ther. Dai 15 12 2966 2016 10.1158/1535-7163.MCT-16-0391 Ascochlorin enhances the sensitivity of doxorubicin leading to the reversal of epithelial-to-mesenchymal transition in hepatocellular carcinoma
Biomed. Pharmacother. Biomed. Pharmacother. Yang 103 699 2018 10.1016/j.biopha.2018.04.072 Inhibition of PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells
Oncotarget Qin 7 27 41421 2016 10.18632/oncotarget.9404 Apigenin inhibits NF-κB and snail signaling, EMT and metastasis in human hepatocellular carcinoma
Biochem. Biophys. Res. Commun. Li 487 1 122 2017 10.1016/j.bbrc.2017.04.029 Application of molecular imaging technology in evaluating the inhibiting effect of apigenin in vivo on subcutaneous hepatocellular carcinoma
Pathol. Res. Pract. Li 216 1 2020 10.1016/j.prp.2019.152701 Apigenin, a flavonoid constituent derived from P. villosa, inhibits hepatocellular carcinoma cell growth by CyclinD1/CDK4 regulation via p38 MAPK-p21 signaling
Anti Cancer Agents Med. Chem. Seydi 16 12 1576 2016 10.2174/1871520616666160425110839 Selective toxicity of apigenin on cancerous hepatocytes by directly targeting their mitochondria
Clin. Exp. Pharmacol. Physiol. Hu 42 2 146 2015 10.1111/1440-1681.12333 5-Fluorouracil combined with apigenin enhances anticancer activity through mitochondrial membrane potential (ΔΨm)-mediated apoptosis in hepatocellular carcinoma
Carcinogenesis Gao 34 8 1806 2013 10.1093/carcin/bgt108 Apigenin sensitizes doxorubicin-resistant hepatocellular carcinoma BEL-7402/ADM cells to doxorubicin via inhibiting PI3K/Akt/Nrf2 pathway
Gene Şirin 737 2020 10.1016/j.gene.2020.144428 Investigation of possible effects of apigenin, sorafenib and combined applications on apoptosis and cell cycle in hepatocellular cancer cells
Mol. Cells Kim 35 1 32 2013 10.1007/s10059-013-2175-2 Sub-toxic dose of apigenin sensitizes HepG2 cells to TRAIL through ERK-dependent up-regulation of TRAIL receptor DR5
Food Chem. Toxicol. Int. J. Brit. Ind. Biol. Res. Assoc. Kang 111 623 2018 10.1016/j.fct.2017.12.018 Apigenin promotes TRAIL-mediated apoptosis regardless of ROS generation
Toxicology Khan 217 2-3 206 2006 10.1016/j.tox.2005.09.019 Apigenin induces apoptosis in Hep G2 cells: possible role of TNF-alpha and IFN-gamma
Chem. Biol. Interact. Valdameri 193 2 180 2011 10.1016/j.cbi.2011.06.009 Involvement of catalase in the apoptotic mechanism induced by apigenin in HepG2 human hepatoma cells
Food Chem. Toxicol. Int. J. Brit. Ind. Biol. Res. Assoc. Kim 49 7 1626 2011 10.1016/j.fct.2011.04.015 A mechanism of apigenin-induced apoptosis is potentially related to anti-angiogenesis and anti-migration in human hepatocellular carcinoma cells
Cancer Lett. Chiang 237 2 207 2006 10.1016/j.canlet.2005.06.002 Anti-proliferative effect of apigenin and its apoptotic induction in human Hep G2 cells
Phytomed. Int. J. Phytother. Phytopharmacol. Cai 18 5 366 2011 Apigenin inhibits hepatoma cell growth through alteration of gene expression patterns
Mol. Carcinog. Jeyabal 44 1 11 2005 10.1002/mc.20115 Apigenin inhibits oxidative stress-induced macromolecular damage in N-nitrosodiethylamine (NDEA)-induced hepatocellular carcinogenesis in Wistar albino rats
Phytomed. Int. J. Phytother. Phytopharmacol. Singh 11 4 309 2004 Protective role of Apigenin on the status of lipid peroxidation and antioxidant defense against hepatocarcinogenesis in Wistar albino rats
Clin. Chest Med. Dela Cruz 32 4 605 2011 10.1016/j.ccm.2011.09.001 Lung cancer: epidemiology, etiology, and prevention
Cancer Lett. Wang 417 152 2018 10.1016/j.canlet.2017.12.030 Pan-HDAC inhibition by panobinostat mediates chemosensitization to carboplatin in non-small cell lung cancer via attenuation of EGFR signaling
Cancer Prev. Res. (Phila.) Quinn 6 8 801 2013 10.1158/1940-6207.CAPR-13-0058-T Inhibition of lung tumorigenesis by metformin is associated with decreased plasma IGF-I and diminished receptor tyrosine kinase signaling
Biomolecules Bordoloi 9 12 836 2019 10.3390/biom9120836 TIPE2 induced the proliferation, survival, and migration of lung cancer cells through modulation of Akt/mTOR/NF-κB signaling cascade
Cancers Jung 11 1 49 2019 10.3390/cancers11010049 Oxymatrine attenuates tumor growth and deactivates STAT5 signaling in a lung cancer xenograft model
Med Clin North Am Nasim 103 3 463 2019 10.1016/j.mcna.2018.12.006 Lung Cancer
J. Experim. Clin. Cancer Res. CR Chang 37 1 199 2018 10.1186/s13046-018-0869-1 Downregulating CD 26/DPPIV by apigenin modulates the interplay between Akt and Snail/Slug signaling to restrain metastasis of lung cancer with multiple EGFR statuses
Int. J. Mol. Med. Kim 34 2 592 2014 10.3892/ijmm.2014.1804 Axl receptor tyrosine kinase is a novel target of apigenin for the inhibition of cell proliferation
Int. J. Nanomedicine Jin 12 5109 2017 10.2147/IJN.S140096 Synergistic apoptotic effects of apigenin TPGS liposomes and tyroservatide: implications for effective treatment of lung cancer
Mol. Pharmacol. Liu 68 3 635 2005 10.1124/mol.105.011254 Apigenin inhibits expression of vascular endothelial growth factor and angiogenesis in human lung cancer cells: implication of chemoprevention of lung cancer
Int. J. Oncol. Lee 48 1 399 2016 10.3892/ijo.2015.3243 Inhibition of glutamine utilization sensitizes lung cancer cells to apigenin-induced apoptosis resulting from metabolic and oxidative stress
Zhong Nan Da Xue Xue Bao. Yi Xue Ban J. Central South Univ. Med. Sci. Shu 41 11 1124 2016 Effects of apigenin on self-renewal and uPAR expression in NCI-H446 cell line
Anti-Cancer Drugs Zhou 28 4 446 2017 10.1097/CAD.0000000000000479 Apigenin inhibits cell proliferation, migration, and invasion by targeting Akt in the A549 human lung cancer cell line
Experim. Biol. Med. (Maywood, N.J.) Das 237 12 1433 2012 10.1258/ebm.2012.012148 Apigenin-induced apoptosis in A375 and A549 cells through selective action and dysfunction of mitochondria
Nan Fang Yi Ke Da Xue Xue Bao J. South. Med. Univ. Pan 33 8 1137 2013 Effect of apigenin on proliferation and apoptosis of human lung cancer NCI-H460 cells
Int. J. Oncol. Lu 36 6 1477 2010 Apigenin induces caspase-dependent apoptosis in human lung cancer A549 cells through Bax- and Bcl-2-triggered mitochondrial pathway
Human Experim. Toxicol. Lu 30 8 1053 2011 10.1177/0960327110386258 Apigenin induces apoptosis in human lung cancer H460 cells through caspase- and mitochondria-dependent pathways
Biochimie Choudhury 95 6 1297 2013 10.1016/j.biochi.2013.02.010 Apigenin shows synergistic anticancer activity with curcumin by binding at different sites of tubulin
Eur. J. Cancer (Oxford, England 1990) Bruno 47 13 2042 2011 10.1016/j.ejca.2011.03.034 Apigenin affects leptin/leptin receptor pathway and induces cell apoptosis in lung adenocarcinoma cell line
Front. Pharmacol. Chen 10 260 2019 10.3389/fphar.2019.00260 Apigenin combined with gefitinib blocks autophagy flux and induces apoptotic cell death through inhibition of HIF-1α, c-Myc, p-EGFR, and glucose metabolism in EGFR L858R+T790M-mutated H1975 cells
Zhejiang Da Xue Xue Bao. Yi Xue Ban J. Zhejiang Univ. Med. Sci. Ren 40 5 508 2011 Anti-proliferation and chemo-sensitization effects of apigenin on human lung cancer cells
Lancet (Lond. Engl.) Maris 369 9579 2106 2007 10.1016/S0140-6736(07)60983-0 Neuroblastoma
Children (Basel, Switzerland) Van Arendonk 6 1 12 2019 Neuroblastoma: tumor biology and its implications for staging and treatment
Mol. Cancer Ther. Torkin 4 1 1 2005 10.1158/1535-7163.1.4.1 Induction of caspase-dependent, p53-mediated apoptosis by apigenin in human neuroblastoma
J. Mol. Neurosci. MN Chakrabarti 51 1 187 2013 10.1007/s12031-013-9975-x Sequential hTERT knockdown and apigenin treatment inhibited invasion and proliferation and induced apoptosis in human malignant neuroblastoma SK-N-DZ and SK-N-BE2 cells
Exp. Cell Res. Chakrabarti 319 10 1575 2013 10.1016/j.yexcr.2013.02.025 miR-138 overexpression is more powerful than hTERT knockdown to potentiate apigenin for apoptosis in neuroblastoma in vitro and in vivo
Mol. Oncol. Mohan 7 3 464 2013 10.1016/j.molonc.2012.12.002 KLF4 overexpression and apigenin treatment down regulated anti-apoptotic Bcl-2 proteins and matrix metalloproteinases to control growth of human malignant neuroblastoma SK-N-DZ and IMR-32 cells
Biochem. Biophys. Res. Commun. Karmakar 388 4 705 2009 10.1016/j.bbrc.2009.08.071 Bcl-2 inhibitor and apigenin worked synergistically in human malignant neuroblastoma cell lines and increased apoptosis with activation of extrinsic and intrinsic pathways
Gene Hossain 529 1 27 2013 10.1016/j.gene.2013.07.094 N-Myc knockdown and apigenin treatment controlled growth of malignant neuroblastoma cells having N-Myc amplification
Arch. Pathol. Lab. Med. Sangle 136 5 572 2012 10.5858/arpa.2011-0204-RS Telangiectatic osteosarcoma
Acta Orthop. Belg. Biazzo 82 4 690 2016 Multidisciplinary approach to osteosarcoma
Padmavathi 81 2017 Mechanism of Chemoresistance in Bone Cancer and Different Chemosensitization Approaches, Cancer Cell Chemoresistance and Chemosensitization
J. Turk. German Gynecol. Assoc. Budiana 20 1 47 2019 10.4274/jtgga.galenos.2018.2018.0119 Ovarian cancer: pathogenesis and current recommendations for prophylactic surgery
Choudhary 529 2017 Cancer Cell Chemoresistance and Chemosensitization Strategies to overcome chemoresistance in ovarian cancer
FEBS Lett. Li 583 12 1999 2009 10.1016/j.febslet.2009.05.013 Apigenin inhibits proliferation of ovarian cancer A2780 cells through Id1
Mol. Med. Rep. Tang 11 3 2221 2015 10.3892/mmr.2014.2974 Apigenin inhibits the self-renewal capacity of human ovarian cancer SKOV3-derived sphere-forming cells
Biomed. Pharmacother. Biomed. Pharmacother. Tavsan 116 2019 Flavonoids showed anticancer effects on the ovarian cancer cells: involvement of reactive oxygen species, apoptosis, cell cycle and invasion
Nutr. Cancer Luo 60 6 800 2008 10.1080/01635580802100851 Inhibition of cell growth and VEGF expression in ovarian cancer cells by flavonoids
Carcinogenesis Hu 29 12 2369 2008 10.1093/carcin/bgn244 Apigenin inhibited migration and invasion of human ovarian cancer A2780 cells through focal adhesion kinase
Int. J. Mol. Sci. He 13 6 7271 2012 10.3390/ijms13067271 Oral administration of apigenin inhibits metastasis through AKT/P70S6K1/MMP-9 pathway in orthotopic ovarian tumor model
Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. Dhillon 14 14 4491 2008 10.1158/1078-0432.CCR-08-0024 Phase II trial of curcumin in patients with advanced pancreatic cancer
World J. Gastroenterol. McGuigan 24 43 4846 2018 10.3748/wjg.v24.i43.4846 Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes
N. Engl. J. Med. Ryan 371 11 1039 2014 10.1056/NEJMra1404198 Pancreatic adenocarcinoma
Int. J. Cancer Kunnumakkara 131 3 E292 2012 10.1002/ijc.26442 Zyflamend suppresses growth and sensitizes human pancreatic tumors to gemcitabine in an orthotopic mouse model through modulation of multiple targets
Sailo 557 2017 Cancer Cell Chemoresistance and Chemosensitization Molecular alterations involved in pancreatic cancer chemoresistance and chemosensitization strategies
Int. J. Cancer Harikumar 127 2 257 2010 10.1002/ijc.25041 Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer
J. Clin. Oncol. Dhillon 25 4599 2007 10.1200/jco.2007.25.18_suppl.4599 Curcumin and pancreatic cancer: phase II clinical trial experience
PLoS One Nelson 12 2 2017 10.1371/journal.pone.0170197 Apigenin: selective CK2 inhibitor increases Ikaros expression and improves T cell homeostasis and function in murine pancreatic cancer
Toxicol. Lett. Wu 224 1 157 2014 10.1016/j.toxlet.2013.10.007 Apigenin potentiates the growth inhibitory effects by IKK-β-mediated NF-κB activation in pancreatic cancer cells
Mol. Cancer Ujiki 5 76 2006 10.1186/1476-4598-5-76 Apigenin inhibits pancreatic cancer cell proliferation through G2/M cell cycle arrest
Mol. Nutr. Food Res. Johnson 57 12 2112 2013 10.1002/mnfr.201300307 Flavonoid apigenin modified gene expression associated with inflammation and cancer and induced apoptosis in human pancreatic cancer cells through inhibition of GSK-3β/NF-κB signaling cascade
Food Chem. Toxicol. Int. J. Brit. Ind. Biol. Res. Assoc. Johnson 60 83 2013 10.1016/j.fct.2013.07.036 Interactions between dietary flavonoids apigenin or luteolin and chemotherapeutic drugs to potentiate anti-proliferative effect on human pancreatic cancer cells, in vitro
J. Experim. Clin. Cancer Res. CR Chien 38 1 246 2019 10.1186/s13046-019-1247-3 Targeting the SPOCK1-snail/slug axis-mediated epithelial-to-mesenchymal transition by apigenin contributes to repression of prostate cancer metastasis
Biochim. Biophys. Acta King 1823 2 593 2012 10.1016/j.bbamcr.2011.12.008 Evidence for activation of mutated p53 by apigenin in human pancreatic cancer
Pancreas Melstrom 37 4 426 2008 10.1097/MPA.0b013e3181735ccb Apigenin inhibits the GLUT-1 glucose transporter and the phosphoinositide 3-kinase/Akt pathway in human pancreatic cancer cells
J. Surg. Res. Melstrom 167 2 173 2011 10.1016/j.jss.2010.10.041 Apigenin down-regulates the hypoxia response genes: HIF-1α, GLUT-1, and VEGF in human pancreatic cancer cells
Mol. Carcinog. Salabat 47 11 835 2008 10.1002/mc.20441 Geminin is overexpressed in human pancreatic cancer and downregulated by the bioflavanoid apigenin in pancreatic cancer cell lines
Pancreas Strouch 38 4 409 2009 10.1097/MPA.0b013e318193a074 The flavonoid apigenin potentiates the growth inhibitory effects of gemcitabine and abrogates gemcitabine resistance in human pancreatic cancer cells
Cancer Lett. Lee 259 1 39 2008 10.1016/j.canlet.2007.09.015 Enhanced anti-tumor effect of combination therapy with gemcitabine and apigenin in pancreatic cancer
Jama Litwin 317 24 2532 2017 10.1001/jama.2017.7248 The diagnosis and treatment of prostate cancer: a review
Prostate Muralimanoharan 69 5 494 2009 10.1002/pros.20899 Butanol fraction containing berberine or related compound from nexrutine inhibits NFkappaB signaling and induces apoptosis in prostate cancer cells
Apoptosis Int. J. Program. Cell Death Zhang 22 1 158 2017 10.1007/s10495-016-1313-7 Cardamonin represses proliferation, invasion, and causes apoptosis through the modulation of signal transducer and activator of transcription 3 pathway in prostate cancer
Cancer Prev. Res. (Phila.) Heymach 4 10 1590 2011 10.1158/1940-6207.CAPR-10-0136 Effect of low-fat diets on plasma levels of NF-κB-regulated inflammatory cytokines and angiogenic factors in men with prostate cancer
Antioxid. Redox Signal. Zhang 24 11 575 2016 10.1089/ars.2015.6418 Nimbolide-induced oxidative stress abrogates STAT3 signaling cascade and inhibits tumor growth in transgenic adenocarcinoma of mouse prostate model
Padmavathi 583 2017 Different Chemosensitization Approaches to Overcome Chemoresistance in Prostate Cancer, Cancer Cell Chemoresistance and Chemosensitization
Life Sci. Erdogan 162 77 2016 10.1016/j.lfs.2016.08.019 The flavonoid apigenin reduces prostate cancer CD44(+) stem cell survival and migration through PI3K/Akt/NF-κB signaling
Fitoterapia Wang 111 66 2016 10.1016/j.fitote.2016.04.014 Suppression of rat and human androgen biosynthetic enzymes by apigenin: possible use for the treatment of prostate cancer
Eur. J. Nutr. Singh 54 8 1255 2015 10.1007/s00394-014-0803-z Apigenin manipulates the ubiquitin-proteasome system to rescue estrogen receptor-β from degradation and induce apoptosis in prostate cancer cells
Mol. Med. Rep. Zhu 11 2 1004 2015 10.3892/mmr.2014.2801 Apigenin inhibits migration and invasion via modulation of epithelial mesenchymal transition in prostate cancer
Apoptosis Int. J. Program. Cell Death Shukla 19 5 883 2014 10.1007/s10495-014-0971-6 Apigenin induces apoptosis by targeting inhibitor of apoptosis proteins and Ku70-Bax interaction in prostate cancer
PLoS One Oishi 8 2 2013 10.1371/journal.pone.0055922 Apigenin sensitizes prostate cancer cells to Apo2L/TRAIL by targeting adenine nucleotide translocase-2
Mol. Carcinog. Mirzoeva 53 8 598 2014 10.1002/mc.22005 Apigenin inhibits TGF-β-induced VEGF expression in human prostate carcinoma cells via a Smad2/3- and Src-dependent mechanism
Mol. Carcinog. Pandey 51 12 952 2012 10.1002/mc.20866 Plant flavone apigenin inhibits HDAC and remodels chromatin to induce growth arrest and apoptosis in human prostate cancer cells: in vitro and in vivo study
Cancer Prev. Res. (Phila.) Franzen 2 9 830 2009 10.1158/1940-6207.CAPR-09-0066 The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism
Mol. Carcinog. Shukla 48 3 243 2009 10.1002/mc.20475 Apigenin suppresses insulin-like growth factor I receptor signaling in human prostate cancer: an in vitro and in vivo study
Carcinogenesis Kaur 29 11 2210 2008 10.1093/carcin/bgn201 Plant flavonoid apigenin inactivates Akt to trigger apoptosis in human prostate cancer: an in vitro and in vivo study
J. Korean Med. Sci. Seo 26 11 1489 2011 10.3346/jkms.2011.26.11.1489 Apoptotic effects of genistein, biochanin-A and apigenin on LNCaP and PC-3 cells by p21 through transcriptional inhibition of polo-like kinase-1
Biomed. Pharmacother. Biomed. Pharmacother. Erdogan 88 210 2017 10.1016/j.biopha.2017.01.056 The natural flavonoid apigenin sensitizes human CD44(+) prostate cancer stem cells to cisplatin therapy
Primary Care Linares 42 4 645 2015 10.1016/j.pop.2015.07.006 Skin cancer
Monisha 479 2017 Chemoresistance and Chemosensitization in Melanoma, Cancer Cell Chemoresistance and Chemosensitization
AAPS J. Paredes-Gonzalez 16 4 727 2014 10.1208/s12248-014-9613-8 Apigenin reactivates Nrf2 anti-oxidative stress signaling in mouse skin epidermal JB6 P + cells through epigenetics modifications
Neoplasia (New York, N.Y.) Mirzoeva 20 9 930 2018 10.1016/j.neo.2018.07.005 Apigenin inhibits UVB-induced skin carcinogenesis: the role of thrombospondin-1 as an anti-inflammatory factor
Cancer Res. Wei 50 3 499 1990 Inhibitory effect of apigenin, a plant flavonoid, on epidermal ornithine decarboxylase and skin tumor promotion in mice
Prostaglandins Leukot. Essent. Fat. Acids Kiraly 104 44 2016 10.1016/j.plefa.2015.11.006 Apigenin inhibits COX-2, PGE2, and EP1 and also initiates terminal differentiation in the epidermis of tumor bearing mice
Int. J. Cancer Caltagirone 87 4 595 2000 10.1002/1097-0215(20000815)87:4<595::AID-IJC21>3.0.CO;2-5 Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential
Nutrients Ghițu 11 4 858 2019 10.3390/nu11040858 A comprehensive assessment of apigenin as an antiproliferative, proapoptotic, antiangiogenic and immunomodulatory phytocompound
Phytomed. Int. J. Phytother. Phytopharmacol. Ye 18 1 32 2010 Flavonoids, apigenin and icariin exert potent melanogenic activities in murine B16 melanoma cells
Exp. Dermatol. Ye 20 9 755 2011 10.1111/j.1600-0625.2011.01297.x Activation of p38 MAPK pathway contributes to the melanogenic property of apigenin in B16 cells
J. Experim. Clin. Cancer Res. CR Xu 37 1 261 2018 10.1186/s13046-018-0929-6 Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects
J. Inorg. Biochem. Spoerlein 127 107 2013 10.1016/j.jinorgbio.2013.07.038 Effects of chrysin, apigenin, genistein and their homoleptic copper(II) complexes on the growth and metastatic potential of cancer cells
Oncol. Lett. Subhasitanont 14 4 4361 2017 10.3892/ol.2017.6705 Apigenin inhibits growth and induces apoptosis in human cholangiocarcinoma cells
Cell Prolif. Hussain 43 2 170 2010 10.1111/j.1365-2184.2009.00662.x Apigenin induces apoptosis via downregulation of S-phase kinase-associated protein 2-mediated induction of p27Kip1 in primary effusion lymphoma cells
J. Experim. Clin. Cancer Res. CR. Granato 36 1 167 2017 10.1186/s13046-017-0632-z Apigenin, by activating p53 and inhibiting STAT3, modulates the balance between pro-apoptotic and pro-survival pathways to induce PEL cell death
J. Cancer Huang 11 8 2123 2020 10.7150/jca.34981 Apigenin and abivertinib, a novel BTK inhibitor synergize to inhibit diffuse large B-cell lymphoma in vivo and vitro
Sailo 615 2017 Cancer Cell Chemoresistance and Chemosensitization Therapeutic strategies for chemosensitization of renal cancer
Int. J. Cancer Gates 121 10 2225 2007 10.1002/ijc.22790 A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer
Am. J. Clin. Nutr. Wang 89 3 905 2009 10.3945/ajcn.2008.26913 Dietary intake of selected flavonols, flavones, and flavonoid-rich foods and risk of cancer in middle-aged and older women
World J. Gastroenterol. Hoensch 14 14 2187 2008 10.3748/wjg.14.2187 Prospective cohort comparison of flavonoid treatment in patients with resected colorectal cancer to prevent recurrence
Mol. Cancer Ther. Sung 8 4 959 2009 10.1158/1535-7163.MCT-08-0905 Curcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model
Biochim. Biophys. Acta Li 1805 2 167 2010 Targeting transcription factor NF-kappaB to overcome chemoresistance and radioresistance in cancer therapy
Front. Pharmacol. Ong 7 395 2016 10.3389/fphar.2016.00395 Judicious toggling of mTOR activity to combat insulin resistance and cancer: current evidence and perspectives
J. Biol. Regul. Homeost. Agents Angelini 24 2 197 2010 Modulation of multidrug resistance p-glycoprotein activity by flavonoids and honokiol in human doxorubicin- resistant sarcoma cells (MES-SA/DX-5): implications for natural sedatives as chemosensitizing agents in cancer therapy
J. Med. Chem. Chan 49 23 6742 2006 10.1021/jm060593+ Flavonoid dimers as bivalent modulators for P-glycoprotein-based multidrug resistance: synthetic apigenin homodimers linked with defined-length poly(ethylene glycol) spacers increase drug retention and enhance chemosensitivity in resistant cancer cells
J. Radiat. Res. Watanabe 48 1 45 2007 10.1269/jrr.0635 The chemopreventive flavonoid apigenin confers radiosensitizing effect in human tumor cells grown as monolayers and spheroids
Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. van Rijn 3 10 1775 1997 Flavonoids as enhancers of X-ray-induced cell damage in hepatoma cells
Ann. Neurol. Staff 81 6 772 2017 10.1002/ana.24951 Chemotherapy-induced peripheral neuropathy: a current review
J. Stem Cells Metri 8 2 115 2013 Ayurveda for chemo-radiotherapy induced side effects in cancer patients
Curr. Opin. Neurol. Cavaletti 28 5 500 2015 10.1097/WCO.0000000000000234 Chemotherapy-induced peripheral neurotoxicity
Crit. Rev. Clin. Lab. Sci. Cao 54 2 87 2017 10.1080/10408363.2016.1261270 Biomarkers for monitoring chemotherapy-induced cardiotoxicity
J. Exp. Med. Cildir 214 9 2491 2017 10.1084/jem.20170910 The transcriptional program, functional heterogeneity, and clinical targeting of mast cells
Cardiol. Clin. Shoukat 37 4 449 2019 10.1016/j.ccl.2019.07.010 Cardiotoxicity related to radiation therapy
Brain Nerve Shinkei Kenkyu No Shinpo Suzuki 67 1 63 2015 Neurotoxicity of radiation
Immunity Cildir 51 5 949 2019 10.1016/j.immuni.2019.09.021 Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases
Cancer Chemother. Sakurai 46 12 1849 2019 [Utility of the predictive score for cisplatin-induced nephrotoxicity in patients with chemotherapy for lung cancer], Gan to kagaku ryoho
Science (New York, N.Y.) Tan 359 6380 1170 2018 10.1126/science.aan0346 Thermal proximity coaggregation for system-wide profiling of protein complex dynamics in cells
Phytother. Res. PTR Psotová 18 7 516 2004 10.1002/ptr.1462 Chemoprotective effect of plant phenolics against anthracycline-induced toxicity on rat cardiomyocytes. Part III. Apigenin, baicalelin, kaempherol, luteolin and quercetin
Phytomed. Int. J. Phytother. Phytopharmacol. Fischer 47 192 2018 Prevention from radiation damage by natural products
Life Sci. Zare 232 2019 10.1016/j.lfs.2019.116623 Apigenin attenuates doxorubicin induced cardiotoxicity via reducing oxidative stress and apoptosis in male rats
Pharm. Biol. Hassan 55 1 766 2017 10.1080/13880209.2016.1275704 Protective effects of apigenin and myricetin against cisplatin-induced nephrotoxicity in mice
Eur. J. Drug Metab. Pharmacokinet. Rašković 42 5 849 2017 10.1007/s13318-017-0407-0 Antioxidative and protective actions of apigenin in a paracetamol-induced hepatotoxicity rat model
Mutat. Res. Genet. Toxicol. Environ. Mutagen. Ali 767 13 2014 10.1016/j.mrgentox.2014.04.006 Protective effect of apigenin against N-nitrosodiethylamine (NDEA)-induced hepatotoxicity in albino rats
J. Biochem. Mol. Toxicol. Mohamed 34 5 2020 10.1002/jbt.22472 Apigenin alleviated acetaminophen-induced hepatotoxicity in low protein-fed rats: targeting oxidative stress, STAT3, and apoptosis signals
Food Chem. Hu 204 274 2016 10.1016/j.foodchem.2016.02.138 Identification of flavonoids from Flammulina velutipes and its neuroprotective effect on pheochromocytoma-12 cells
Mutat. Res. Rithidech 585 1-2 96 2005 10.1016/j.mrgentox.2005.04.003 Protective effect of apigenin on radiation-induced chromosomal damage in human lymphocytes
Mutat. Res. Begum 747 1 71 2012 10.1016/j.mrgentox.2012.04.001 Apigenin ameliorates gamma radiation-induced cytogenetic alterations in cultured human blood lymphocytes
Int. J. Mol. Med. Choi 38 2 627 2016 10.3892/ijmm.2016.2626 Apigenin inhibits UVA-induced cytotoxicity in vitro and prevents signs of skin aging in vivo
Mutat. Res. Rithidech 749 1-2 29 2012 10.1016/j.mrgentox.2012.08.001 Attenuation of oxidative damage and inflammatory responses by apigenin given to mice after irradiation
Int. J. Pharm. Karim 532 2 757 2017 10.1016/j.ijpharm.2017.04.064 Development and evaluation of injectable nanosized drug delivery systems for apigenin
Food Chem Toxicol Das 670 2013 10.1016/j.fct.2013.09.037 Efficacy of PLGA-loaded apigenin nanoparticles in Benzo[a]pyrene and ultraviolet[HYPHEN]B induced skin cancer of mice: mitochondria mediated apoptotic signalling cascades
Artif. Cells Nanomed. Biotechnol. Jangdey 45 7 1452 2017 10.1080/21691401.2016.1247850 Development and optimization of apigenin-loaded transfersomal system for skin cancer delivery: in vitro evaluation
Drug Deliv. Jangdey 24 1 1026 2017 10.1080/10717544.2017.1344333 Fabrication, in-vitro characterization, and enhanced in-vivo evaluation of carbopol-based nanoemulsion gel of apigenin for UV-induced skin carcinoma
Artif. Cell Nanomed. Biotechnol. Jangdey 47 1 904 2019 10.1080/21691401.2019.1578784 Efficacy of Concanavalin-A conjugated nanotransfersomal gel of apigenin for enhanced targeted delivery of UV induced skin malignant melanoma
Food Chem. Toxicol. Int. J. Brit. Ind. Biol. Res. Assoc. Das 62 670 2013 10.1016/j.fct.2013.09.037 Efficacy of PLGA-loaded apigenin nanoparticles in Benzo[a]pyrene and ultraviolet-B induced skin cancer of mice: mitochondria mediated apoptotic signalling cascades
Toxicol. Lett. Das 223 2 124 2013 10.1016/j.toxlet.2013.09.012 Strategic formulation of apigenin-loaded PLGA nanoparticles for intracellular trafficking, DNA targeting and improved therapeutic effects in skin melanoma in vitro
Colloids Surf. B: Biointerfaces Sen 180 9 2019 10.1016/j.colsurfb.2019.04.035 Dual drug loaded liposome bearing apigenin and 5-fluorouracil for synergistic therapeutic efficacy in colorectal cancer
Nanomed. Nanotechnol. Biol. Med. Bhattacharya 14 6 1905 2018 10.1016/j.nano.2018.05.011 Apigenin loaded nanoparticle delayed development of hepatocellular carcinoma in rats
Anti Cancer Agents Med. Chem. Pal 17 12 1721 2017 Synergistic effect of graphene oxide coated nanotised apigenin with paclitaxel (GO-NA/PTX): a ROS dependent mitochondrial mediated apoptosis in ovarian cancer
Biochem. Biophys. Res. Commun. Gupta 287 4 914 2001 10.1006/bbrc.2001.5672 Selective growth-inhibitory, cell-cycle deregulatory and apoptotic response of apigenin in normal versus human prostate carcinoma cells
Baek 2016 Method for Improving Anti-cancer Effect of Apigenin by Irradiation and Pharmaceutical Composition for Treating or Preventing Cancer Comprising Irradiated Apigenin
Xiaoli 2016 Granules for Assisting in Radiation Resistance in Tumor Interventional Therapy
Cheol-woo 2017 Pharmaceutical Compositions for Preventing or Treating Lung Cancer Comprising Apigenin, Curcumin, and Honokiol as Active Ingredients
Cheng 2017 Applications of Apigenin for Preparation of Medicines Inhibiting Liver Cancer Epithelial-mesenchymal Transition
Lihua 2018 Applications of Apigenin in Preparation of Gastric Cancer Treatment Drugs
Lihua 2018 Application of Apigenin in Preparation of Drugs Used for Treating Rectal Cancer
Lihua 2018 Application of Apigenin in Preparation of Drugs Used for Treating Pancreas Cancer
Lihua 2018 Application of Apigenin to Prepare Medicine for Treating Cervical Cancer
Lihua 2018 Application of Apigenin to Prepare Medicine for Treating Tongue Cancer
Lihua 2018 Application of Apigenin to Preparation of Drugs Capable of Resisting Lung Cancer Metastasis
Lihua 2018 Application of Apigenin to Prepare Medicine for Treating Ileocecal Cancer
Lihua 2018 Application of Apigenin in Preparation of Drugs Used for Treating Nasopharyngeal Carcinoma
Zuohuan 2018 Flavonoid Derivatives and a Preparation Method and Uses
Cheng 2018 Flavonoids and Their Application in Anticancer Drugs
Lihua 2018 Application of Apigenin in Preparation of Drugs Used for Treating Breast Cancer
Lihua 2018 Use of Apigenin in Preparation of Drugs for Treating Endometrial Cancer
Jian 2017 Application of Apigenin in Inhibition of Activation of Wnt/beta-catenin Signal Channel of Colon Cancer Cell
Lihua 2018 Use of Apigenin in Preparation of Drug for Treating Laryngeal Cancer
Lihua 2018 Application of Apigenin in Preparation of Cholangiocarcinoma Treatment Drugs
Cheol-woo 2018 Pharmaceutical Composition Comprising Apigenin, Curcumin, and Honokiol as Active Ingredients for Preventing or Treating Lung Cancer
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.